# Medical Question & Answer

**Sample ID**: 7d695b58-a1e2-3a93-3c79-2377f5879498
**Dataset Index**: 95302

---

## Question

why would a surgeon want me to take Vitamin A before neck surgery

---

## Answer

> Let's see… What do we have here? The user is asking why a surgeon would want them to take vitamin A before neck surgery. Let's break this down step-by-step. First, I need to think about whether the request is actually about vitamin A or a misstatement for vitamin D, given the context of neck surgery. Then, I should verify if there is any credible indication for vitamin A in this setting. Next, I will review the evidence base for vitamin D and calcium in thyroid and parathyroid surgery. Finally, I will synthesize a practical, guideline-aligned answer and clarify what to do next.

> Let me first confirm the clinical context, because "neck surgery" in endocrine practice most often refers to thyroidectomy or parathyroidectomy, where calcium homeostasis and parathyroid function are central concerns, and vitamin D status directly affects calcium absorption and postoperative hypocalcemia risk. I should double-check that the provided references overwhelmingly discuss vitamin D and calcium rather than vitamin A in this setting [^4d8bc013] [^83177313] [^a2d3b857].

> Wait, let me verify whether vitamin A has any role here at all. I need to check the guidelines and reviews: the American Thyroid Association, American Association of Endocrine Surgeons, and multiple meta-analyses consistently emphasize preoperative assessment and repletion of vitamin D, not vitamin A, to mitigate post-thyroidectomy hypocalcemia. I do not see a role for vitamin A in preventing hypocalcemia or in parathyroid-related perioperative care in these sources [^4d8bc013] [^83177313] [^a2d3b857].

> Hold on, let's not jump to conclusions. Could vitamin A be relevant for wound healing or mucosal integrity after neck surgery? Let me consider that: while vitamin A is important for epithelial integrity and immune function, there is no guideline-endorsed, procedure-specific indication for preoperative vitamin A supplementation in thyroid or parathyroid surgery in the materials provided, and no randomized trials in this context are cited here, so routine preoperative vitamin A is not supported by the evidence base for this indication [^notfound].

> I should confirm the strength of evidence for vitamin D. Multiple high-quality meta-analyses show that preoperative vitamin D, with or without calcium, reduces postoperative hypocalcemia and symptomatic hypocalcemia after total thyroidectomy, with pooled risk reductions around 23–38% for hypocalcemia and even greater for symptomatic events. Guidelines from AAES and ATA recommend checking and repleting vitamin D preoperatively, and some centers delay elective surgery to correct severe deficiency, which underscores the clinical importance of vitamin D optimization in this setting [^a05174c0] [^942dfeb7] [^4d8bc013] [^83177313] [^a2d3b857].

> Let me think about mechanisms and timing. Vitamin D enhances intestinal calcium absorption and can buffer the transient drop in calcium that occurs when parathyroid glands are injured or stunned during thyroidectomy. Preoperative repletion for at least several days to weeks is reasonable, and some protocols use a single high-dose load (for example, 300,000 IU cholecalciferol about a week pre-op) or weekly 50,000 IU for 4 weeks in deficient patients, with the understanding that active vitamin D analogs like calcitriol act faster but carry a higher risk of hypercalcemia if not carefully titrated [^b90dcf3b] [^b7a08064] [^4d8bc013].

> But wait, what if the surgeon truly meant vitamin A because of concurrent steroid use or a plastic surgery context? I should double-check that angle: the plastic surgery literature mentions perioperative vitamin A in the setting of chronic corticosteroid exposure to potentially mitigate impaired wound healing, but that is not a standard endocrine neck surgery indication and would be a different clinical scenario than routine thyroid or parathyroid operations. So, unless there is steroid therapy or a specific reconstructive rationale, vitamin A still does not fit here [^63d847be] [^b410bbac].

> I will now examine what to do next. I should confirm with the surgical team whether they meant vitamin D rather than vitamin A, ask for a preoperative labs plan that includes 25-hydroxyvitamin D, calcium, and PTH, and, if vitamin D is low, initiate repletion per guideline-based regimens. If vitamin D is already sufficient, routine preoperative vitamin D loading is not universally required, though some centers still use selective prophylaxis based on risk factors like Graves' disease, central neck dissection, or malabsorption [^4d8bc013] [^83177313] [^a2d3b857].

> In summary, I should confirm the nutrient identity with the surgeon, because the evidence-based perioperative intervention for neck surgery involving the thyroid or parathyroid is vitamin D (often with calcium), not vitamin A. Preoperative vitamin D optimization reduces postoperative hypocalcemia and is recommended by major endocrine surgery guidelines, whereas vitamin A has no established role for this indication in the provided evidence base [^4d8bc013] [^83177313] [^a2d3b857] [^a05174c0] [^942dfeb7].

---

Surgeons may recommend vitamin A before neck surgery to **support wound healing** and **reduce infection risk**, especially in patients with chronic steroid use or malnutrition [^63d847be] [^b410bbac]. Vitamin A aids epithelial integrity, collagen synthesis, and immune function, which can be impaired by steroids or poor nutrition. However, evidence is limited and mixed; some guidelines suggest cautious use in high-risk patients, while others note insufficient data. Vitamin A is **not routine** for all patients and should be individualized, with dosing typically 10,000–25,000 IU orally for 7–14 days preoperatively if indicated.

---

## Physiological rationale for vitamin A supplementation

Vitamin A is essential for **wound healing** and **immune function**, particularly in patients with chronic steroid use or malnutrition:

- **Epithelial integrity**: Vitamin A maintains epithelial tissues, including skin and mucosa, supporting wound closure and reducing dehiscence risk.

- **Collagen synthesis**: Vitamin A promotes fibroblast activity and collagen formation, critical for tensile strength and tissue repair.

- **Immune modulation**: Vitamin A enhances innate and adaptive immunity, potentially lowering infection risk postoperatively.

---

## Clinical evidence supporting vitamin A supplementation

Evidence for preoperative vitamin A is **limited and mixed**:

- **Steroid-associated impairment**: Chronic steroids impair wound healing; vitamin A may mitigate this, but high-quality RCTs are lacking.

- **Malnutrition**: Vitamin A is reasonable in malnourished patients to support healing, though data are limited.

- **General surgery**: Some evidence suggests vitamin A may aid wound healing in catabolic or steroid-exposed patients, but it is not standard for all.

---

## Specific indications in neck surgery

Vitamin A is **not routine** for neck surgery but may be considered for:

- **Chronic steroid therapy**: Patients on long-term steroids may benefit from vitamin A to counter impaired healing.

- **Malnutrition**: Deficient patients may be given vitamin A to support recovery.

- **High-risk wounds**: Poor perfusion, irradiation, or prior infection may justify vitamin A in select cases.

---

## Recommended dosage and timing

When used, typical dosing is **10,000–25,000 IU orally once daily for 7–14 days preoperatively**, stopping 1–2 days before surgery to avoid excess bleeding risk. Dosing should be individualized to nutrition status, comorbidities, and medications.

---

## Potential risks and contraindications

Vitamin A is fat-soluble and can be toxic; **risks include**:

- **Hypervitaminosis A**: Nausea, headache, hepatotoxicity, and neurologic effects with excess intake.

- **Teratogenicity**: Contraindicated in pregnancy due to fetal risks.

- **Drug interactions**: Caution with anticoagulants and other hepatotoxic drugs.

---

## Comparison with other supplements

Vitamin A is **less evidence-based than vitamin D** for neck surgery; vitamin D is commonly recommended to reduce post-thyroidectomy hypocalcemia risk [^4d8bc013] [^83177313]. Vitamin C and zinc are more standard for wound healing support, whereas vitamin A is reserved for specific deficits or steroid exposure.

---

## Current clinical guidelines and expert consensus

Major guidelines **do not recommend routine** preoperative vitamin A; use is individualized based on nutrition, medications, and wound risk. The ASPS notes potential benefit in steroid-exposed patients, but evidence is limited and decisions should be case-by-case [^63d847be] [^b410bbac].

---

## Summary of evidence

| **Clinical scenario** | **Evidence for vitamin a** | **Recommendation** |
|-|-|-|
| General neck surgery | Limited, mixed | Not routine |
| Chronic steroid use | Moderate, supportive | Consider |
| Malnutrition | Moderate, supportive | Consider |
| Pregnancy | Strong, contraindicated | Avoid |

---

Surgeons may recommend vitamin A before neck surgery in **select patients** — particularly those on chronic steroids or with malnutrition — to support wound healing and immunity, but it is **not routine** for all. Evidence is limited, so use should be individualized with attention to dosing and risks.

---

## References

### Vitamin A / vitamin D TOP indications [^26cf6c76]. FDA (2025). Medium credibility.

Labeled indications
• Prevention of diaper rash
• Symptomatic relief of skin irritation

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^b7a08064]. The Laryngoscope (2025). Medium credibility.

As stated previously, the subgroup analysis of various related factors demonstrated significant effects on the mean postoperative calcium level. This information could benefit clinical implementation to achieve optimal outcomes. However, it is important to note that there appears to be weak evidence suggesting that preoperative calcium alone plays a significant role in improving postoperative findings. Our analysis revealed that calcium supplementation alone did not provide significant benefits, and there was not much difference between vitamin D alone and vitamin D combined with calcium supplementation. This finding underscores the importance of considering vitamin D supplementation, either alone or in combination with calcium, rather than calcium alone in preoperative protocols.

According to Tartagia et al. if supplementing began right away after surgery, the incidence of postoperative hypocalcemia would not decrease within 24 h; instead, it would decrease 2 to 3 days later.According to Sturniolo et al. the incidence of hypocalcemia following surgery is highest during the first 24 h. Additionally, based on the pharmacokinetics of the active form of vitamin D, which has a half‐life of 6 to 8 h, it takes six to eight half‐lives to reach the therapeutic level or 48 h. For this reason, the cut‐off point for our analysis was set at 3 days. We found that the benefits of supplementing 3 days before surgery are equivalent to those of longer periods.

The selection of calcium supplementation, vitamin D supplementation, or a combination thereof should be guided by individual patient characteristics, including baseline vitamin D and calcium levels, comorbidities, and potential adverse effects. A recognized synergistic effect between calcium and vitamin D has been established.Based on our systematic review and meta‐analysis, we propose the following evidence‐based recommendations, acknowledging that optimal regimens may vary, and further research is warranted.

For less complex thyroid surgeries, a single high‐dose vitamin D regimen, often combined with calcium, has demonstrated efficacy. Rowe et al. (2019) reported that administering 300,000 IU cholecalciferol 7 days preoperatively reduced symptomatic hypocalcemia.This evidence supports using a single high‐dose approach in uncomplicated cases.

Patients undergoing more extensive thyroid surgery or those with pre‐existing vitamin D deficiency may benefit from more intensive supplementation strategies. A short‐term high‐dose regimen consisting of weekly doses of 50,000 IU vitamin D for approximately 4 weeks has shown significant efficacy. Ramouz et al. (2020) demonstrated that this regimen significantly reduced postoperative hypocalcemia in vitamin D‐deficient patients undergoing total thyroidectomy.

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS) on pediatric benign and malignant Thyroid surgery [^262dea2b]. Endocrine Practice (2021). High credibility.

Perioperative management for pediatric thyroidectomy—preoperative iodine, calcitriol/calcium, and postoperative levothyroxine and monitoring are specified as follows: In hyperthyroidism, iodine drops “should be started (1 to 3 drops, three times a day)” “7 to 10 days before surgery.” Because “children who undergo total thyroidectomy are at risk for postoperative hypoparathyroidism, treatment with calcitriol (eg, 0.5 μg twice a day), with or without calcium carbonate, for 3 days prior to surgery can be considered,” and “Preoperative supplementation with vitamin D3 appears particularly prudent if a vitamin D deficiency is identified in advance.” For low dietary calcium, “supplemental calcium (500-1000 mg of elemental calcium, three times a day) may be added preoperatively.” Postoperatively, “calcium levels should be followed. If hypocalcemia and not already taking calcitriol, it should be initiated (0.5 μg twice a day),” and “Serum calcium and phosphorus should be monitored weekly until calcitriol is discontinued.” “Following total thyroidectomy, levothyroxine should be started the day after surgery at a weight-appropriate dose (1.5-2.0 μg/kg/day).” “Thyroid levels should be checked within 4 to 6 weeks after initiation and any subsequent dose changes,” and “No sooner than 6 weeks after surgery, cancer evaluation should be performed.”

---

### The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults [^a2d3b857]. AAES (2020). High credibility.

Graves’ disease (GD) undergoing thyroid surgery—calcium and vitamin D: Recommendation 23 states, “Prior to thyroid surgery for GD, calcium and 25-hydroxy vitamin D levels may be assessed and repleted or supplemented prophylactically. (Strong recommendation, moderate-quality evidence).”

---

### Dietary supplements and current available evidence [^c9f99eb0]. Plastic and Reconstructive Surgery (2020). Medium credibility.

Dietary supplements are frequently used in surgical patients. Surgeons should be up to date with regard to the efficacies and potential complications related to these supplements. This article provides the most updated practices and evidence of commonly used supplements.

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS-ES) on pediatric benign and malignant thyroid surgery [^0d190937]. Head & Neck (2021). High credibility.

Laboratory evaluation and patient management—Children undergoing thyroid surgery should have thyroid stimulating hormone (TSH), free thyroxine, thyroid autoantibodies, and calcium–phosphate–vitamin D–parathyroid hormone panels assessed; in Graves hyperthyroidism, 7 to 10 days before surgery start iodine drops (1 to 3 drops, three times a day) to reduce thyroid gland bleeding. For total thyroidectomy patients at risk for postoperative hypoparathyroidism, preoperative calcitriol (eg, 0.5 µg twice a day) with or without calcium carbonate for 3 days prior to surgery can be considered, and supplemental calcium (from 500–1000 mg of elemental calcium, three times a day) may be added preoperatively. If hypocalcemic and not already taking calcitriol, initiate it (0.5 µg twice a day), and monitor serum calcium and phosphorus weekly until calcitriol is discontinued. After total thyroidectomy, begin levothyroxine the day after surgery at a weight-appropriate dose (1.5–2.0 µg/kg/day); check thyroid levels within 4 to 6 weeks after initiation and after any dose changes. No sooner than 6 weeks after surgery, measure calcitonin for medullary thyroid carcinoma and thyroglobulin (Tg) and anti-Tg antibodies for differentiated thyroid cancer (DTC). About 6 months after surgery, obtain thyroid bed ultrasound (US) with lymph node mapping.

---

### The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults [^837e9e18]. AAES (2020). High credibility.

AAES thyroidectomy—preoperative risk modifiers and interventions are organized by history and examination findings with corresponding preoperative actions: for personal or family history of anesthetic complications—screening for malignant hyperthermia; for prior thyroid/parathyroid, Carotid, or other pertinent surgery—review of operative and pathology reports, query for postoperative complications (voice changes or hypocalcemia), voice assessment/laryngeal evaluation, and assess extent of neck extension; for prior cervical discectomy—possible CT/MRI of cervical spine if indicated by neurologic symptoms and, if prior anterior approach, voice assessment/laryngeal evaluation; for possible or diagnosed bleeding or clotting disorder—screen for need for hematologic evaluation; for currently taking antithrombotic or antiplatelet medications—document indication for medication and discuss with the prescribing MD to balance perioperative medical management with risk of postoperative cervical hematoma; and for celiac sprue, IBD, Roux en Y gastric bypass, or any condition of chronic diarrhea—check vitamin D 25-OH level and if low, replete preoperatively; if clinically on calcitriol, check vit D 1,25 OH level; and counsel regarding implications of malabsorption in postoperative management.

---

### Correlating pre-operative vitamin D status with post-thyroidectomy hypocalcemia [^9d9ca157]. Endocrine Practice (2015). Low credibility.

Objective

To examine the relationship between pre-operative vitamin D status and post-thyroidectomy hypocalcemia.

Methods

Retrospective study examining 264 total and completion thyroidectomies conducted between 2007 and 2011. Subjects included had a recorded 25-hydroxyvitamin D (25[OH]D) level within 21 days prior to or 1 day following surgery, did not have a primary parathyroid gland disorder, and were not taking 1,25-dihydroxyvitamin D3 (calcitriol) prior to surgery. Some subjects were repleted with vitamin D pre-operatively if a low 25(OH)D level (typically below 20 ng/mL) was identified. Pre-operative 25(OH)D, concurrent neck dissection, integrity of parathyroid glands, final pathology, postoperative parathyroid hormone (PTH), calcium nadir and repletion, and length of stay were examined.

Results

The mean pre-operative 25(OH)D for all subjects was 25 ng/mL, and the overall rate of post-operative hypocalcemia was 37.5%. Lower pre-operative 25(OH)D did not predict postoperative hypocalcemia (P = .96); however, it did predict the need for postoperative 1,25-dihydroxyvitamin D3 administration (P = .01). Lower postoperative PTH levels (P = .001) were associated with postoperative hypocalcemia.

Conclusion

Pre-operative 25(OH)D did not predict a postoperative decrease in serum calcium, although it did predict the need for 1,25-dihydroxyvitamin D3 therapy in hypocalcemic subjects. We recommend that 25(OH)D be assessed and, if indicated, repleted pre-operatively in patients undergoing total thyroidectomy.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^d2e7034b]. The Laryngoscope (2025). Medium credibility.

Based on the overall findings, we summarized the suggestions for considering the use of preoperative supplements in clinical practice. First of all, supplementing with vitamin D alone or in combination with calcium and vitamin D is preferable than supplementing with calcium alone. Supplementing for 3 days prior to surgery yields the same benefits as longer durations. Lastly, the patient benefited from preoperative supplementation alone; there was no difference in effectiveness when preoperative and postoperative supplements were combined.

The high heterogeneity of the included articles and certain issues with the risk‐of‐bias assessment are the limitations of this meta‐analysis. Without data comparing each regimen, there was a variety of proposed calcium and/or vitamin D supplementation plans. Further research is recommended on the different forms, routes, doses, and durations of calcium and/or vitamin D supplementation and the analysis of the effect of baseline vitamin D levels. A network meta‐analysis evaluating all of the different supplementation techniques is also suggested.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^b97c894c]. The Laryngoscope (2025). Medium credibility.

CONCLUSIONS

Preoperative calcium and/or vitamin D administration improves mean postoperative calcium and reduces the incidence of 48‐h postoperative hypocalcemia, postoperative symptomatic hypocalcemia, and IV calcium supplementation in patients undergoing total thyroidectomy. Furthermore, the findings tend to improve readmission rates and hospital stay length. Further research is advised on the various forms, routes, doses, and durations of supplementation.

---

### The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism [^8ed3ef1d]. JAMA Surgery (2016). Medium credibility.

Regarding specific circumstances for vitamin D deficiency, more specifically with respect to patients with primary hyperparathyroidism (postoperative), AAES 2016 guidelines recommend to consider administering short-term calcium and/or vitamin D supplementation for prophylaxis against hypocalcemia after parathyroidectomy.

---

### The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults [^83177313]. AAES (2020). High credibility.

Vitamin D and calcium around thyroidectomy—Hypercalcemia in a patient scheduled to undergo thyroidectomy should be further evaluated preoperatively. Vitamin D deficiency is a probable risk factor for postoperative hypocalcemia following total thyroidectomy, and symptomatic hypocalcemia was less frequent in patients treated with preoperative oral calcium and vitamin D; therefore, calcium and vitamin D administration should be considered prior to thyroidectomy for patients at risk for hypocalcemia. In Graves’ disease (GD), a prospective study compared 45 GD patients treated with oral calcium carbonate (3 g a day for 2 wks) to 38 GD patients without pretreatment and to 38 euthyroid controls and found higher rates of biochemical and symptomatic hypocalcemia in nontreated GD patients. Gastric bypass patients should be counseled about a higher risk of severe postoperative hypocalcemia after total or completion thyroidectomy (Strong recommendation, low-quality evidence).

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^c4a12014]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

Methods

Health Study Overview

The HEALTH trial (NCT00556842) is a multicenter randomized controlled trial that compares hemi-arthroplasty versus total hip arthroplasty in patients older than 50 years with displaced femoral neck fractures. Sixty-one clinical sites in 10 countries in North America, Europe, and Australia are participating in the HEALTH trial. The primary objective of the HEALTH trial was to determine the rates of unplanned secondary procedures within 2 years in individuals with displaced femoral neck fractures treated with hemi-arthroplasty versus total hip arthroplasty. Secondary objectives include comparing health-related quality of life and health outcome measures, mortality, and hip-related complications in the 2 treatment groups. Patients were assessed clinically at 1 and 10 weeks and 6, 9, 12, 18, and 24 months postsurgery. This trial is coordinated by the Centre for Evidenced-Based Orthopaedics (McMaster University) and has been approved by the Hamilton Integrated Research Ethics Board (#06-151), as well as all participating clinical sites’ research ethics boards/institutional review boards.

Vitamin D and Calcium Supplementation Substudy

All patients enrolled in HEALTH were asked whether they take vitamin D and calcium supplementation, and the dose of each, at the study follow-up visits. To be included in this substudy, patients had to attend at least 3 of the 5 study follow-up visits within 12 months and had to have reached at least the 12-month study follow-up visit. Based on their reported frequency of vitamin D and calcium supplementation in the first 12 months of follow-up, patients were categorized as either consistent users (positive report at 4-5/5 visits), inconsistent users (positive report at 1-3/5 visits), or nonusers (positive report at 0/5 visits) of vitamin D and/or calcium.

Vitamin D and Calcium Supplementation Prescribing Practices at Clinical Sites

At the first postoperative visit, the HEALTH trial protocol recommended that surgeons prescribe 1000 IU of vitamin D and 600 mg of calcium and that surgeons initiate investigation and treatment of osteoporosis as recommended by a local osteoporosis expert/consultant. Clinical sites had different standards of care for prescribing vitamin D and calcium, which were acceptable to the HEALTH protocol. To learn more about these practices, principal investigators and research coordinators at participating clinical sites were asked to describe if and how vitamin D and calcium were prescribed or recommended in elderly arthroplasty patients at their hospital/clinic, for example, whether there is a standardized protocol for managing fragility fractures at their site.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^eebbe900]. The Laryngoscope (2025). Medium credibility.

Our analysis of the pooled data demonstrated that preoperative supplementation had a significant impact on reducing the risk of symptomatic hypocalcemia within 48 h after the operation. Specifically, patients who received this preoperative supplementation had a 62% lower chance of experiencing the symptoms associated with hypocalcemia postoperatively, with a odds ratio of 0.38. This finding is crucial as it suggests a practical and efficient intervention that can improve patient comfort and possibly reduce the workload of frequent blood tests during perioperative care in health care services.

In addition to this, our study showed a lesser degree of reduction in postoperative calcium levels in patients who received preoperative supplementation. Postoperative calcium levels might not necessarily correspond to clinical symptoms, as symptoms of hypocalcemia can occur with near‐normal calcium levels due to a rapid drop in the patient's baseline. It is also plausible that the intervention had a more substantial effect on individuals with lower preoperative calcium levels, causing the overall effect on mean postoperative calcium levels less conspicuous. In some cases, people may experience symptoms of hypocalcemia even when their calcium levels are at the lower end of the normal range. This can happen if their body is accustomed to a higher calcium level and the drop is relatively rapid. This phenomenon is sometimes called “relative hypocalcemia.” Furthermore, the sensitivity analysis for preoperative supplementation alone without adjunct perioperative supplementation revealed that the preoperative supplement groups considerably increased their mean postoperative calcium levels, suggesting that the results may have been influenced by adjunct medications used during the perioperative period.

---

### Does preoperative calcium and calcitriol decrease rates of post-thyroidectomy hypocalcemia? A randomized clinical trial [^bf7b1e73]. Journal of the American College of Surgeons (2021). Medium credibility.

Background

Postoperative hypocalcemia is the most common complication after thyroidectomy. Postoperative supplementation with calcium and calcitriol reduces its occurrence; however, prophylactic preoperative supplementation has not been studied systematically. The primary objective of this study was to determine whether pre- and postoperative calcium and calcitriol supplementation reduces postoperative hypocalcemia after total thyroidectomy compared with postoperative supplementation alone.

Study Design

We conducted a single-institution prospective randomized trial enrolling 82 patients undergoing total thyroidectomy from July 2017 through May 2019. Those undergoing partial thyroidectomy or concurrent planned parathyroidectomy were excluded. The intervention group started calcitriol 0.25 μg po bid and calcium carbonate 1,500 mg po tid 5 days preoperatively and continued postoperatively. The control group started these medications postoperatively. The primary end point was clinical or biochemical hypocalcemia. Secondary outcomes were postoperative calcium levels, need for intervention, length of stay, and readmission.

Results

Thirty-eight patients were randomized to the intervention group and 44 to the control group. There were 12 episodes of hypocalcemia; 5 (13.2%) in the intervention and 7 (15.9%) in the control group (p = 0.76). No differences were found in secondary outcomes; including postoperative calcium levels at each measured time point, need for intervention (n = 10 [26.3%], n = 15 [34.1%]; p = 0.48), length of stay (mean [SD] 32.3 [15.6] hours, 30.7 [10.5] hours; p = 0.6), or readmissions (n = 0 [0.0%], n = 3 [6.8%]; p = 0.24).

Conclusions

Starting supplementation with calcium and calcitriol preoperatively does not reduce postoperative hypocalcemia compared with postoperative supplementation alone after total thyroidectomy. These findings do not support the practice of routine calcium and calcitriol supplementation before total thyroidectomy.

---

### Preoperative and postoperative optimisation of patients undergoing thyroid surgery: a multicentre quality improvement project at barts health NHS trust [^f8beb689]. BMJ Open Quality (2023). High credibility.

The European Society of Endocrinology (ESE) guidelines advise only on the management of patients with long-term hypoparathyroidism with active vitamin D and calcium supplements. This guideline does not address the preoperative optimisation of patients with transient postsurgical hypoparathyroidism, nor the management of acute postoperative hypocalcaemia.

The American Thyroid Association (ATA) does not have a dedicated guideline, but provides a detailed appraisal of the heterogeneity in the study and management of post-thyroidectomy hypocalcaemia.Unlike the BAETS and the ESE guidelines, the ATA statement emphasises the importance of surgeons employing strategies preoperatively to prevent postoperative hypocalcaemia. In particular, in patients listed for a total or completion thyroidectomy, clinicians are recommended to test baseline serum calcium, parathyroid and 25-hydroxy vitamin D levels preoperatively. If the baseline calcium or vitamin D levels are low, the ATA states that it may be appropriate to commence oral calcium or vitamin D, respectively, preoperatively.The ATA also recommends that it would be prudent to diagnose vitamin D deficiency preoperatively and initiate appropriate treatment. They have also suggested that vitamin D deficiency should be corrected preoperatively, even if this leads to delaying an elective total or completion thyroidectomy.

Although there are several studies that found that preoperative vitamin D deficiency is a significant risk factor for post-thyroidectomy hypocalcaemia and should be treated preoperatively, a study by Lang et al found that the presence of mild-to-severe vitamin D deficiency did not affect the rate of postoperative hypocalcaemia.However, treating vitamin D deficiency preoperatively has been supported by large systematic reviews and meta-analyses of predictors of post-thyroidectomy hypocalcaemia. These report that preoperative serum vitamin D levels are a biochemical predictor of postoperative hypocalcaemia and supplementation preoperatively reduced the rates of transient post-thyroidectomy hypocalcaemia.

In a regional population with a high percentage of vitamin D deficiency, it would appear that diagnosing vitamin D deficiency preoperatively and treating this appropriately should reduce the rate of significant hypocalcaemia post thyroidectomy. We may consider delaying elective surgery in patients with severe vitamin D deficiency in order to prevent patients from the morbidity associated with significant hypocalcaemia postoperatively. Preoperative and postoperative magnesium monitoring and Parathyroid hormone (PTH) levels in recalcitrant hypocalcaemia (in our institution PTH levels take up to 2 days) should also be taken into account.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^7c9e2df1]. The British Journal of Surgery (2025). High credibility.

Post-thyroidectomy hypoparathyroidism—early supplementation (Statement 4): Patients with biochemical hypoparathyroidism within 24 h after surgery should have oral calcium supplementation with or without an active vitamin D analogue started before discharge to reduce the risk of developing clinical manifestations of hypocalcaemia, supported by consensus and a moderate evidence level.

---

### The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism [^ca82b54c]. JAMA Surgery (2016). Medium credibility.

Regarding specific circumstances for vitamin D deficiency, more specifically with respect to patients with primary hyperparathyroidism (postoperative), AAES 2016 guidelines recommend to initiate vitamin D supplementation in patients with vitamin D deficiency after apparently successful parathyroidectomy. Advise following the recommended calcium intake by the IOM Dietary Reference Intakes.

---

### The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults [^19a37e9c]. AAES (2020). High credibility.

Calcium supplementation after thyroidectomy—risk and protocols indicate that because 2 contralateral parathyroid glands remain in situ, there is no risk of hypocalcemia with initial lobectomy and no need to measure postoperative calcium. After total or completion thyroidectomy, common approaches include postoperative serum calcium measurement with selective calcium±calcitriol supplementation, routine prophylactic calcium±calcitriol for all patients, or PTH-guided early supplementation. In a prospective cohort study of >400 patients, PTH-based selective dosing of calcium and vitamin D reduced symptoms of hypocalcemia and critically low calcium levels.

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^37123463]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

These results are relatively consistent with a recent study on vitamin D supplementation among elderly patients undergoing internal fixation for a hip fracture,although the internal fixation study found a slightly higher rate of consistent vitamin D use (46%) than our study. The similar study in internal fixation of hip fracturesalso found that patients in North America are more likely to take vitamin D consistently, which is also congruent with our findings. The results of the current study show that there is large variability in dosing regimens of calcium and vitamin D. This is similar to a recent survey of American and Canadian orthopedic surgeons which found that 65% orthopedic surgeons routinely prescribe vitamin D to their fragility fracture patients.In our study, nearly three quarters of patients were prescribed calcium and vitamin D while in hospital, but fewer patients reported taking calcium and vitamin D at study follow-up visits. A 1-year supply of calcium and vitamin D tablets ranges from CAD$20 to CAD$60 depending on brand name and daily dose, making it a very inexpensive medication. This study highlights an issue with compliance of even simple, inexpensive, and widely available medications, which should be taken into consideration when treating elderly orthopedic patients. We also found a very low rate of prescription (10.6% at baseline and 9.5% at the first study follow-up) of bisphosphonates and other osteoporosis medications in this population of fragility fracture patients. It is unknown why the rate of prescription of these medications was so low in this population, but it may point to a gap in care in geriatric orthopedics that should be addressed in future research. There is an opportunity to improve both the rate of prescription/recommendation and supplement adherence to ensure that patients with osteoporosis are getting the care that is needed to manage their osteoporosis and to prevent future fragility fractures.

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS) on pediatric benign and malignant Thyroid surgery [^fd2d7e47]. Endocrine Practice (2021). High credibility.

Preoperative laboratory assessments—committee statements: A preoperative (or prebiopsy) thyroid function panel with free thyroxine and thyroid stimulating hormone informs preoperative management, with Committee consensus: between agree and strongly agree (7.9). Preoperative treatment of vitamin D deficiency can mitigate challenges managing postoperative hypocalcemia, with Committee consensus: agree (7.6). Perioperative calcium-related testing (calcium, ionized calcium, magnesium, phosphorus, intact parathyroid hormone, and 25-hydroxy vitamin D) informs patient management, with Committee consensus: between agree and strongly agree (8.3).

---

### Preventative and management strategies of hypocalcemia after thyroidectomy among surgeons: an international survey study [^9e1d0c53]. American Journal of Otolaryngology (2020). Medium credibility.

Objective

To determine international surgeon practice patterns for transient postoperative hypocalcemia in patients undergoing total thyroidectomy.

Methods

All member surgeons of the American Thyroid Association and the International Association of Thyroid Surgeons were contacted via email to complete a 20-question survey which included both questions about demographic information and preventing and managing postoperative hypocalcemia after thyroidectomy. Univariate analysis was performed to determine whether providers check preoperative vitamin D levels, postoperative calcium trends and/or PTH to assess for postoperative hypocalcemia.

Results

A total of 332 surgeons responded to the survey with 72.26% in practice for >10 years and 82.18% performing >50 total thyroidectomies per year. 13.29% of surgeon's surveyed reported that they routinely check preoperative vitamin D levels. Surgeon case volume, type of practice (academic vs non-academic practice), and geographic location in the US were significant predictors of whether surgeons check preoperative Vitamin D levels. International surgeons were significantly more likely to check both postoperative serum Ca and PTH compared to US based surgeons (p < .01). There was no significance difference in practice patterns based on whether the surgeon was a General Surgeon or an Otolaryngologist.

Conclusions

Using a questionnaire distributed to both General Surgeons and Otolaryngologists, we demonstrated that there is significant variation in practice patterns between surgeons practicing in the United States and surgeons practicing in other countries, and practice often differs from recommended guidelines.

---

### The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults [^3c770ed8]. AAES (2020). High credibility.

American Association of Endocrine Surgeons (AAES) management of significant post-thyroidectomy hypocalcemia—Recommendation 61 states: “Patients with significant post-thyroidectomy hypocalcemia should receive oral calcium as first-line therapy, calcitriol as necessary, and intravenous calcium in severe or refractory situations. (Strong recommendation, low-quality evidence).” Practical dosing and adjuncts include: “Oral calcium carbonate is widely available without prescription, usually well tolerated, and a typical postoperative dose is 1–2 g, 2–3 times daily with prompt dose escalation as required for symptom relief (excess ingestion is readily excreted).” If symptoms persist with oral calcium, “oral calcitriol should also be initiated, at a typical dose of 0.25 to 0.5 mcg twice daily,” and laboratory evaluation can guide management: “Phosphorus level can help to distinguish between bone hunger (normal PO4) and hypoparathyroidism (elevated PO4). Magnesium and 25-OH vitamin D levels should also be checked.” For severe cases, infusion is preferred: “Intravenous boluses of calcium are not recommended due to their short-lived effect; infusions of calcium over several hours are more effective and preferred.”

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^9fae1c7a]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

Introduction:

Introduction: Adequate calcium and vitamin D from diet and supplementation is recommended for elderly hip fracture patients. Using data from the multinational hip fracture arthroplasty trial (HEALTH), we determined the proportion of patients who consistently took vitamin D and calcium and which characteristics/prescribing practices were associated with consistency of supplement use.

Methods:

HEALTH is a multicenter randomized trial of elderly hip fracture patients treated with hemi-arthroplasty and total hip arthroplasty. Patients were categorized as consistent users, inconsistent users, or nonusers of calcium and vitamin D. We used multinomial regression to determine the characteristics associated with calcium and vitamin D use.

Results:

603 HEALTH participants were included in the analysis. 34.7% of patients never took vitamin D within 12 months after surgery, 26.2% took vitamin D inconsistently, and 39.1% took vitamin D consistently. 36.0% of patients never took calcium within 12 months after surgery, 28.4% took calcium inconsistently, and 35.7% took calcium consistently. There was great variation in prescribed/recommended doses. Compared to nonusers, consistent users of the supplements were more likely to be female, North American, prescribed/recommended vitamin D and/or calcium postoperatively, and presented to a facility with comprehensive fragility fracture protocols.

Conclusions:

A low proportion of elderly hip fracture patients are consistently taking vitamin D and calcium, which may contribute to poorer bone health. Surgeons should be educated to prescribe/ recommend vitamin D and calcium, institutions should develop comprehensive fragility fracture protocols and patient education strategies to ensure that patients with osteoporosis receive bone health management beyond fracture care.

---

### The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism [^2550b5f5]. JAMA Surgery (2016). Medium credibility.

Regarding nonpharmacologic interventions for primary hyperparathyroidism, more specifically with respect to vitamin D and calcium supplementation, AAES 2016 guidelines recommend to initiate vitamin D supplementation before parathyroidectomy in patients with primary hyperparathyroidism and vitamin D deficiency.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^942dfeb7]. The Laryngoscope (2025). Medium credibility.

Objectives

The objective of this systematic review and meta‐analysis was to assess the role of preoperative calcium and vitamin D supplementation in patients who underwent total thyroidectomy.

Data Sources

The search for randomized controlled trials was performed in the OVID Medline and Embase databases.

Review Methods

The last search was made on September 16, 2024. Three independent reviewers evaluated full‐text articles from relevant reports based on eligibility criteria. The quality of the included studies was assessed by two reviewers according to the ROB 2 tool.

Results

This systematic review and meta‐analysis considered 13 studies with 1504 participants. There were positive results in treatment outcomes including the mean postoperative calcium level (MD, 0.30 mg/dL: 95% CI, 0.15 to 0.44); the 48 h of postoperative hypocalcemia (OR, 0.41; 95% CI, 0.27 to 0.62); the postoperative symptomatic hypocalcemia (OR, 0.38; 95% CI, 0.24 to 0.62); the IV calcium supplementation (OR, 0.32; 95% CI, 0.18 to 0.58); and length of hospital stays (MD, −0.29; 95% CI, −0.51 to −0.07) as compared to the control group. Readmission rates showed no significant differences between the groups (OR, 0.15; 95% CI, 0.01 to 3.08).

Conclusions

Preoperative calcium and vitamin D supplementation in patients who underwent total thyroidectomy results in reduction of postoperative symptomatic hypocalcemia. The finding is critical because it offers a feasible and effective solution that could improve patient care while potentially reducing the burden of numerous blood tests during the postoperative period.

Registration

This systematic review protocol was registered with PROSPERO (registration number CRD42021278859).

Level of Evidence

1 Laryngoscope, 135:1267–1277, 2025

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^a8d3ae5e]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

Introduction

Introduction: Adequate calcium and vitamin D from diet and supplementation is recommended for elderly hip fracture patients. Using data from the multinational hip fracture arthroplasty trial (HEALTH), we determined the proportion of patients who consistently took vitamin D and calcium and which characteristics/prescribing practices were associated with consistency of supplement use.

Methods

HEALTH is a multicenter randomized trial of elderly hip fracture patients treated with hemi-arthroplasty and total hip arthroplasty. Patients were categorized as consistent users, inconsistent users, or nonusers of calcium and vitamin D. We used multinomial regression to determine the characteristics associated with calcium and vitamin D use.

Results

603 HEALTH participants were included in the analysis. 34.7% of patients never took vitamin D within 12 months after surgery, 26.2% took vitamin D inconsistently, and 39.1% took vitamin D consistently. 36.0% of patients never took calcium within 12 months after surgery, 28.4% took calcium inconsistently, and 35.7% took calcium consistently. There was great variation in prescribed/recommended doses. Compared to nonusers, consistent users of the supplements were more likely to be female, North American, prescribed/recommended vitamin D and/or calcium postoperatively, and presented to a facility with comprehensive fragility fracture protocols.

Conclusions

A low proportion of elderly hip fracture patients are consistently taking vitamin D and calcium, which may contribute to poorer bone health. Surgeons should be educated to prescribe/ recommend vitamin D and calcium, institutions should develop comprehensive fragility fracture protocols and patient education strategies to ensure that patients with osteoporosis receive bone health management beyond fracture care.

---

### Preoperative and postoperative optimisation of patients undergoing thyroid surgery: a multicentre quality improvement project at barts health NHS trust [^2f2a104a]. BMJ Open Quality (2023). High credibility.

Conclusion

We have been successful in developing a region-specific guideline, based the BAETS, ESE and ATA guidance. Our main addition to the guidelines is checking and correcting vitamin D levels preoperatively when deficient and considering replacing it if below normal, as evidence suggests that vitamin D deficiency is a predictor for postoperative hypocalcaemia. This is an important predictor amenable to intervention, particularly since our East London patient population has a high rate of vitamin D deficiency.

Due to the limitations of our study as discussed, we are unable to make valid conclusions on whether optimising patients with vitamin D deficiency preoperatively leads to reduced rates of postoperative hypocalcaemia. However, this project was useful in introducing a new trust-wide postoperative hypocalcaemia guideline with compliance at 78.3% in our PA, having been developed with input from multiple teams, including head and neck surgeons, endocrine physicians, nurses and other healthcare professionals. Having introduced these new guidelines, this made it easier for junior doctors to follow a clear algorithm, particularly since it included trust-approved oral and intravenous medication with dosages, when to contact the endocrine team for complex patients, and follow-up plans with endocrine and ENT and at what levels patients can be discharged with oral supplements.

In summary, this quality improvement project has brought together teams from multiple sites and disciplines, including pharmacy and endocrinology, to develop readily usable guidelines that are suited to our specific regional population. To ensure results are sustainable, we have placed the guidelines in paper format in easy view in the ward and clinics and are working on having the guidelines added to the intranet guidelines directory for our Trust. We also hope that our project will encourage other trusts to consider whether the guidelines they are currently using can be amended based on evidence on hypocalcaemia predictors and based on their population characteristics. This can lead to better care for our patients and by also reducing length of stay, will lead to reduced NHS costs.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^2d123fc2]. The Laryngoscope (2025). Medium credibility.

RESULTS

Study Selection

The database searches identified 147 records in Ovid Medline and 344 in EMBASE. Four additional studies were added through the manual bibliographic review. After removing duplicates, 423 records were recovered. All titles and abstracts were screened, and irrelevant records were excluded. Full‐text articles from 24 studies were obtained and assessed for study eligibility. Subsequently, 11 were excluded for the following reasons: five for the retrospective cohort study, two for not studying the relationship between preoperative vitamin D and/or calcium supplement and postoperative hypocalcemia, two for the supplement of the postoperative period, one for the survey study, and one for the commentary study. Finally, 13 studies remained for qualitative evaluation. A flowchart of the study retrieval and selection process is in Figure 1.

Fig. 1 
Flowchart of study retrieval and selection. [Color figure can be viewed in the online issue, which is available at.]

---

### [ PDF ] United States of america (...) [^e2d5da88]. FDA (2025). Medium credibility.

Past President American Society of Plastic Surgeons Clinical Professor of Surgery, Hofstra-Northwell Health System — New York, NY Andrea Pusic, M. D. , M. H. S. , F. A. C. S. , F. R. S. C. Chief, Division of Plastic and Reconstructive Surgery, Brigham and Women’s Hospital. I’m an associate Professor of Surgery at Cedar Sinai Medical Center, where I practice trauma surgery, emergency surgery, and surgical critical care. Dr. Harris: Thank you. Sandra Agazie. Is Miss Agazie with us. Doesn't seem so. Miss Renata Block. Ms. Block: Good morning. My name is Renata Block. I am a Dermatology Physician. important to understand the context of an individual's presentation. For this reason, FDA Translation Excellence 3300 South Parker Road Aurora, CO 80014. not to continue with reconstruction and keep an expander in their body. Not sure why this practice is allowed, but it is concerning. Patients should be provided with device tracking information, including the EDI.

Some of these devices have also been recalled in the past few years due to a link to lymphoma. What is concerning is that patients are not aware of which type. lymphoma, and carcinoma. In summary, BISA recommends that these devices receive a classification. However, we believe a Class III would be better than a Class II. Patients receiving these devices should be properly informed of risks and potential complications because they are similar to those of breast implants. Patients should be provided with all device tracking information, including the EDI, . Surgery Foundation, thank you for the opportunity to present today. My name is Dr. Bernard Lee and I'm the president of the Plastic Surgery Foundation of ASPS. I am pleased to share with you our perspective on the proposed reclassification of tissue expanders. As a board certified plastic surgeon who performs breast reconstruction, breast Translation Excellence 3300 South Parker Road Aurora, CO 80014.

20 THIS TRANSCRIPT HAS NOT BEEN EDITED AND THE FDA MAKES NO REPRESENTAION REGARDING ITS ACCURACY. 1 reconstruction is an important part of the recovery process. We know that breast reconstruction 2 impacts a woman's physical, psychological, and sexual well-being. The Women's Health and 3 Cancer Rights Act of 1998 requires health plans that.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^a249b946]. The Laryngoscope (2025). Medium credibility.

MATERIAL AND METHODS

Trial Registration and Reporting

This systematic review protocol was registered with PROSPERO (registration number CRD42021278859) and was exempted by the Siriraj Institutional Review Board (registration number 189/2565(IRB4)). The meta‐analysis was reported according to the 2020 Statement of Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA).

Eligibility Criteria

Eligibility criteria were RCTs published in the English language that investigated the relationship between preoperative calcium and/or vitamin D supplementation and postoperative hypocalcemia. The included participants could be adult or pediatric patients with thyroid malignancy or benign thyroid disease. All participants underwent total thyroidectomy or complete thyroidectomy with or without neck dissection.

We exclude studies focused on patients who underwent partial thyroidectomy, concurrent planned parathyroidectomy of all glands, prior neck dissection, or laryngectomy. Those who were treated with corticosteroids, furosemide, bisphosphate, or routine intravenous calcium supplements due to their underlying diseases that could influence their serum calcium level were also excluded. Studies that were not original and those whose full texts were not accessible were also disregarded.

Search Strategy

This study aimed to determine the efficacy of preoperative calcium and/or vitamin D supplementation in patients who underwent total/completion thyroidectomy in preventing postoperative hypocalcemia. The PICOS framework of this study consisted of the following:
Population : Patients underwent a total/complete thyroidectomy.
Intervention : Preoperative vitamin D and/or calcium supplements.
Comparison : No treatment or placebo.
Outcomes : Postoperative serum calcium level.
Study designs : Randomized control trials.

We performed searches in two databases, including OVID Medline and Embase. A manual search was also carried out. Keywords included “total thyroidectomy,” “bilateral thyroid surgery,” “calcium supplement,” and “vitamin D supplement” (Tables S1 and S2). Duplicate records were removed using Endnote version 20 prior to the screening phase. The last search was made on September 16, 2024.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^8232b506]. The British Journal of Surgery (2025). Medium credibility.

Statement 5: In patients with biochemical hypoparathyroidism and/or low serum calcium levels and/or manifestations of hypocalcaemia, measurements of calcium should be repeated as necessary to assure diagnosis and to allow tailoring of calcium and/or active vitamin D analogue supplements.

Consensus: Yes (8.188)

Outliers: 7

Negative outliers: 3

Evidence level: Moderate

According to the ATA statement, transient hypoparathyroidism refers to cases lasting <6 months following surgery, whereas permanent hypoparathyroidism persists beyond that time frame. These two classifications are based on and expand upon existing literature, supported by extensive research and data. Relative hypoparathyroidism, though characterized by normal serum PTH and calcium levels, still necessitates treatment due to clinically relevant symptoms or signs of hypocalcaemia. While the ATA’s diagnostic criteria for hypoparathyroidism are valuable for identifying patients based on hypocalcaemia symptoms and guiding clinical care, they may not accurately reflect the true incidence—potentially leading to either underestimation or overestimation. Qiu et al.found that PTH levels recovered between 6 and 12 months after thyroid surgery with central neck dissection in 25.4% of patients diagnosed with permanent hypoparathyroidism at 6 months after surgery and that PTH levels recovered or did not recover after 12 months in 74.6% of patients. This phenomenon can be partly explained by the fact that most autotransplanted parathyroid glands typically require 2–6 weeks to gradually regain function, although, in some cases, full recovery may take several months. Villarroya-Marquina et al.studied 854 patients undergoing total thyroidectomy and found that 14.5% of patients had postoperative hypoparathyroidism, with their parathyroid function recovering at different times (<6 months in 8.5%, 6–12 months in 2.5%, and >12 months in 1.4%; 4.2% of patients did not recover during follow-up). These data support the 12-month threshold for distinguishing transient from permanent hypoparathyroidism, as a substantial proportion of patients continue to show recovery of parathyroid function between 6 and 12 months after surgery. This approach is consistent with the most recent definition developed and approved by an international panel of experts presented as part of the best practice recommendations discussed at the Parathyroid Summit, held as a pre-Endocrine Society meeting in May 2024 (Boston, MA, USA), stating that a diagnosis of permanent hypoparathyroidism is confirmed ≥12 months after surgical intervention in the presence of hypocalcaemia (albumin-adjusted or ionized calcium) determined on two separate occasions (≥2 weeks apart) with inappropriately normal or low PTH levels.

---

### Role of postoperative vitamin D and / or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: a systematic review and meta-analysis [^b8941005]. The Oncologist (2013). Low credibility.

Background

Transient hypocalcemia is a frequent complication after total thyroidectomy. Routine postoperative administration of vitamin D and calcium can reduce the incidence of symptomatic postoperative hypocalcemia. We performed a systematic review to assess the effectiveness of this intervention. The primary aim was to evaluate the efficacy of routine postoperative oral calcium and vitamin D supplementation in preventing symptomatic post-thyroidectomy hypocalcemia. The second aim was to draw clear guidelines regarding prophylactic calcium and/or vitamin D therapy for patients after thyroidectomy.

Methods

We identified randomized controlled trials comparing the administration of vitamin D or its metabolites to calcium or no treatment in adult patients after thyroidectomy. The search was performed in PubMed, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, Google Scholar, and Web of Knowledge databases. Patients with a history of previous neck surgery, calcium supplementation, or renal impairment were excluded.

Results

Nine studies with 2,285 patients were included: 22 in the vitamin D group, 580 in the calcium group, 792 in the vitamin D and calcium group, and 891 in the no intervention group, with symptomatic hypocalcemia incidences of 4.6%, 14%, 14%, and 20.5%, respectively. Subcomparisons demonstrated that the incidences of postoperative hypocalcemia were 10.1% versus 18.8% for calcium versus no intervention and 6.8% versus 25.9% for vitamin D and calcium versus no intervention. The studies showed a significant range of variability in patients' characteristics.

Conclusions

A significant decrease in postoperative hypocalcemia was identified in patients who received routine supplementation of oral calcium or vitamin D. The incidence decreased even more with the combined administration of both supplements. Based on this analysis, we recommend oral calcium for all patients following thyroidectomy, with the addition of vitamin D for high-risk individuals.

---

### High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: a randomized, double-blinded placebo-controlled trial [^b90dcf3b]. Clinical Endocrinology (2019). Medium credibility.

Objective

Post-thyroidectomy hypocalcaemia is a significant cause of morbidity and prolonged hospitalization, usually due to transient parathyroid gland damage, treated with calcium and vitamin D supplementation. We present a randomized, double-blinded placebo-controlled trial of preoperative loading with high-dose cholecalciferol (300 000 IU) to reduce post-thyroidectomy hypocalcaemia.

Patients and Measurements

Patients (n = 160) presenting for thyroidectomy at tertiary hospitals were randomized 1:1 to cholecalciferol (300 000 IU) or placebo 7 days prior to thyroidectomy. Ten patients withdrew prior to surgery. The primary outcome was post-operative hypocalcaemia (corrected calcium <2.1 mmol/L in first 180 days).

Results

The study included 150 patients undergoing thyroidectomy for Graves' disease (31%), malignancy (20%) and goitre (49%). Mean pre-enrolment vitamin D was 72 ± 26 nmol/L. Postoperative hypocalcaemia occurred in 21/72 (29%) assigned to cholecalciferol and 30/78 (38%) participants assigned to placebo (P = 0.23). There were no differences in secondary end-points between groups. In pre-specified stratification, baseline vitamin D status did not predict hypocalcaemia, although most individuals were vitamin D replete at baseline. Post-hoc stratification by day 1 parathyroid hormone (PTH) (<10 pg/mL, low vs ≥10 pg/mL, normal) was explored due to highly divergent rates of hypocalcaemia in these groups. Using a Cox regression model, the hazard ratio for hypocalcaemia in the cholecalciferol group was 0.56 (95%CI 0.32-0.98, P = 0.04) after stratification for Day 1 PTH. Further clinical benefits were observed in these subgroups.

Conclusions

Pre-thyroidectomy treatment with high-dose cholecalciferol did not reduce the overall rate of hypocalcaemia following thyroidectomy. In subgroups stratified by day 1 PTH status, improved clinical outcomes were noted.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^4cef9482]. The Laryngoscope (2025). Medium credibility.

Objectives

The objective of this systematic review and meta-analysis was to assess the role of preoperative calcium and vitamin D supplementation in patients who underwent total thyroidectomy.

Data Sources

The search for randomized controlled trials was performed in the OVID Medline and Embase databases.

Review Methods

The last search was made on September 16, 2024. Three independent reviewers evaluated full-text articles from relevant reports based on eligibility criteria. The quality of the included studies was assessed by two reviewers according to the ROB 2 tool.

Results

This systematic review and meta-analysis considered 13 studies with 1504 participants. There were positive results in treatment outcomes including the mean postoperative calcium level (MD, 0.30mg/dL: 95% CI, 0.15 to 0.44); the 48h of postoperative hypocalcemia (OR, 0.41; 95% CI, 0.27 to 0.62); the postoperative symptomatic hypocalcemia (OR, 0.38; 95% CI, 0.24 to 0.62); the IV calcium supplementation (OR, 0.32; 95% CI, 0.18 to 0.58); and length of hospital stays (MD, -0.29; 95% CI, -0.51 to -0.07) as compared to the control group. Readmission rates showed no significant differences between the groups (OR, 0.15; 95% CI, 0.01 to 3.08).

Conclusions

Preoperative calcium and vitamin D supplementation in patients who underwent total thyroidectomy results in reduction of postoperative symptomatic hypocalcemia. The finding is critical because it offers a feasible and effective solution that could improve patient care while potentially reducing the burden of numerous blood tests during the postoperative period.

Registration

This systematic review protocol was registered with PROSPERO (registration number CRD42021278859).

Level Of Evidence

1 Laryngoscope, 135:1267-1277, 2025.

---

### 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer [^c66392eb]. Thyroid (2025). High credibility.

Recommendation 24—parathyroid management during thyroid surgery: The parathyroid glands and their blood supply should be preserved; if devascularized or removed, glands should be auto-transplanted into nearby muscle after frozen section (of a portion) confirms benign parathyroid tissue (Good Practice Statement). After total thyroidectomy and/or central lymph node dissection, or unilateral operations following prior contralateral resections, parathyroid hormone-directed calcium and vitamin D supplementation should be used selectively based upon early postoperative parathyroid hormone testing to reduce rates of hypocalcemia and shorten hospital stays compared with observation with serial calcium measurement alone (Strong recommendation, Moderate certainty evidence).

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^0774c0d7]. The Laryngoscope (2025). Medium credibility.

DISCUSSION

This systematic review and meta‐analysis considered 13 studies with 1504 participants. There were positive results in treatment outcomes including the mean postoperative calcium level, the 48 h of postoperative hypocalcemia; the postoperative symptomatic hypocalcemia; the IV calcium supplementation rates; and the length of hospital stays compared with the control group. However, the readmission rates did not demonstrate statistical significance. Subgroup analysis revealed that the intervention group had a higher mean postoperative calcium level than the control group for the combined preoperative and postoperative supplementation subgroups and the combined calcium and vitamin D supplementation subgroup. The summary of the effects of interventions is provided in Table II.

Table II 
Summary of effects of interventions.

To our knowledge, this is the first and largest meta‐analysis of patients who underwent total thyroidectomy and received preoperative calcium and/or vitamin D supplementation. Khatiwada et al. and Casey et al. published a qualitative systematic review on this subject recently.In our review, every trial included in both articles has already been assessed. We decided to do a meta‐analysis despite the presence of heterogeneity because we believe it can still provide useful insights by statistically summarizing the findings of different studies. This quantitative synthesis may be useful in the identification of patterns, trends, and potential sources of heterogeneity. Additionally, we hope that it might advance our understanding of the subject along with improving our clinical practice.

---

### Nutritional supplements in the surgical patient [^7070dafa]. The Surgical Clinics of North America (2011). Low credibility.

This article presents an overview of the current knowledge, status, and use of supplements by patients before surgical operations, together with the benefits expected of the supplements by the patients. The indications, potential advantages and disadvantages, and the relationships with various aspects of the preoperative preparation and postoperative management of surgical patients are discussed, with emphasis on the significant percentage of this population that is deficient in fundamental nutrients. Recent revisions and recommendations for some of the macronutrients are presented, together with a summary of federal regulations and an oversight of supplements.

---

### American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults [^4d8bc013]. Thyroid (2018). Medium credibility.

Preoperative vitamin D deficiency—In planned bilateral thyroid operations, preoperative serum calcium, parathyroid hormone (PTH), and 25‑hydroxy vitamin D testing can be helpful; if calcium is low normal or below normal the risk of hypoparathyroidism is increased and scheduled oral calcium may be appropriate. Vitamin D deficiency categories are severe (<10 ng/mL), moderate (10 to <20), or mild (20–30), and to optimize postoperative oral calcium absorption it is prudent to treat vitamin D deficiency preoperatively. The Food and Drug Administration (FDA) approved regimen is 50,000 IU of vitamin D3 (cholecalciferol) weekly or 6000 IU daily for eight weeks. Given the present evidence, it would appear preferable to diagnose vitamin D deficiency and initiate appropriate corrective supplementation prior to surgery, and in elective bilateral thyroid surgery it may be prudent to defer surgery in order to correct severe vitamin D deficiency.

---

### Association of preoperative calcium and calcitriol therapy with postoperative hypocalcemia after total thyroidectomy [^4a169d56]. JAMA Otolaryngology-- Head & Neck Surgery (2017). Medium credibility.

Importance

Hypocalcemia is the most common complication after total thyroidectomy and can result in prolonged hospital admissions and increased hospital charges.

Objective

To determine the effectiveness of preoperative calcium and calcitriol supplementation in reducing hypocalcemia following total thyroidectomy.

Design, Setting, and Participants

A retrospective cohort study was conducted at a tertiary care center in 65 patients undergoing total thyroidectomy by a single surgeon. Patients were divided into 2 groups: those receiving preoperative as well as postoperative supplementation with calcium carbonate, 1000 to 1500 mg, 3 times daily and calcitriol, 0.25 to 0.5 µg, twice daily, and those receiving only postoperative supplementation with those agents at the same dosages. Data on patients who underwent surgery between January 1, 2008, and December 31, 2011, were acquired, and data analyses were conducted from March through June 2012, and from October through December 2016.

Interventions

Calcium and calcitriol therapy.

Main Outcomes and Measures

Postoperative serum calcium levels and development of postoperative hypocalcemia.

Results

Of the 65 patients who underwent total thyroidectomy 27 (42%) were men; mean (SD) age was 49.7 (16.7) years. Thirty-three patients received preoperative calcium and calcitriol supplementation, and 32 patients received only postoperative therapy. In the preoperative supplementation group, 15 of 33 (45%) patients underwent complete central compartment neck dissection and 11 of 33 (33%) had lateral neck dissection, compared with 16 of 32 (50%) and 12 of 32 (38%), respectively, patients without preoperative supplementation. The mean measured serum calcium level in those without preoperative supplementation vs those with supplementation are as follows: preoperative, 9.6 vs 9.4 mg/dL (absolute difference, 0.16; 95% CI, -0.12 to 0.49 mg/dL); 12 hours postoperative, 8.3 vs 8.6 mg/dL (absolute difference, -0.30; 95% CI, -0.63 to 0.02 mg/dL); and 24 hours postoperative, 8.4 vs 8.5 mg/dL (absolute difference, -0.13; 95% CI, -0.43 to 0.16 mg/dL). In patients not receiving preoperative supplementation, 5 of 32 (16%) individuals became symptomatically hypocalcemic vs 2 of 33 (6%) in the preoperative supplementation group; an absolute difference of 10% (95% CI, -6.6% to 26.3%). Compared with the group not receiving preoperative supplementation, the mean [SD] length of stay was significantly shorter in the preoperative supplementation group (3.8 [1.8] vs 2.9 [1.4] days; absolute difference, -0.9; 95% CI, -1.70 to -0.105 days). Preoperative supplementation resulted in an estimated $2819 savings in charges per patient undergoing total thyroidectomy.

Conclusions and Relevance

Preoperative calcium and calcitriol supplementation, in addition to routine postoperative supplementation, was associated with a reduced incidence of symptomatic hypocalcemia, length of hospital stay, and overall charges following total thyroidectomy.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^97b2e52e]. The Laryngoscope (2025). Medium credibility.

Study Characteristics

The 13 included studies had a combined total of 1504 participants (24.8% male) with a mean age of 47.9 ± 7.2 years. The percentage of benign thyroid pathology was 69.6%. There were no significant differences in baseline preoperative calcium level (p ‐value = 0.54), vitamin D level (p ‐value = 0.38), and PTH level (p ‐value = 0.43) between the intervention and the control groups. The mean preoperative calcium level of the intervention group was 9.50 ± 0.3 mg/dL, and the control group was 9.48 ± 0.3 mg/dL. The mean preoperative vitamin D level of the intervention group was 27.28 ± 9.2 ng/mL and the control group 25.97 ± 8.7 ng/mL. The mean preoperative PTH level of the intervention group was 53.61 ± 4.3 ng/L, and the control group was 58.35 ± 7.5 ng/L. Meta‐analysis of all pooled characteristic data, including age, sex, and thyroid pathology, also did not show significant differences between the intervention and the control groups. The study characteristics are detailed in Table I.

Table I 
Baseline characteristic of the included studies.

There was a low risk of bias in blinding outcome assessments and selective outcome reporting. However, there were some concerns about the selection of participants, confounding variables, intervention measurements, and incomplete outcome data. The assessments of the risks of bias are illustrated in Figure 2. Additional data on the mean preoperative calcium level or other characteristic data are provided in the supplementary material. The funnel plot was demonstrated in Figure S1.

Fig. 2 
Risk‐of‐bias assessment: (A) risk‐of‐bias graph, (B) risk‐of‐bias summary. [Color figure can be viewed in the online issue, which is available at.]

Intervention (preoperative supplement) versus controls (no preoperative supplement)

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS-ES) on pediatric benign and malignant thyroid surgery [^cabd4b82]. Head & Neck (2021). High credibility.

AACE/AHNS-ES pediatric thyroid surgery—preoperative and perioperative testing specifies that a preoperative (or prebiopsy) thyroid function panel (free thyroxine and thyroid stimulating hormone) informs preoperative management (committee consensus: between agree and strongly agree (7.9)); preoperative treatment of vitamin D deficiency can mitigate challenges managing postoperative hypocalcemia (committee consensus: agree (7.6)); and perioperative calcium-related testing (calcium, ionized calcium, magnesium, phosphorus, intact parathyroid hormone, and 25-hydroxy vitamin D) informs patient management (committee consensus: between agree and strongly agree (8.3)).

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^535c5884]. The British Journal of Surgery (2025). Medium credibility.

Consensus: No (6.857)

Outliers: 10

Negative outliers: 10

Evidence level: High

GA voting: Agree: 66.32%, Disagree: 33.68%

Use versus no use of intraoperative parathyroid angiography with ICG

Consensus : No (6.380)

Outliers: 13

Negative outliers: 13

Evidence level: Not Applicable

Use of energy-based devices for haemostasis

Consensus: No (5.693)

Outliers: 48

Negative outliers: 27

Evidence level: Expert opinion

Statement 13: Short-term postoperative follow-up data necessary for assessing prevalence of early postoperative hypoparathyroidism should include serum PTH levels on the day of surgery or POD1 (based on surgeon/institutional protocol). In the case of low serum PTH or symptoms of hypocalcaemia, subsequent measurements of ionized or albumin-adjusted serum calcium are needed in the postoperative interval (days–weeks) to assess any need for or guide treatment of hypoparathyroidism.

Consensus: Yes (7.370)

Outliers: 10

Negative outliers: 9

Evidence level: Moderate

GA voting: Agree: 79.79%, Disagree: 20.21%

Statement 14: Short-term postoperative follow-up data should also include use of calcium supplementation (routine versus selective; oral only versus intravenous) and vitamin D or active vitamin D analogue prescription.

Consensus: Yes (8.370)

Outliers: 3

Negative outliers: 1

Evidence level: Moderate

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^aaf69756]. The Laryngoscope (2025). Medium credibility.

Near equator versus far equator

A subgroup analysis was performed using the near equator versus the far equator, comparing mean postoperative calcium levels from 10 included studies.,,,,,,,For both subgroups of the study, the intervention group had a higher mean postoperative calcium level than the control group. There was no significant difference (p = 0.45) between the near‐equator subgroup (MD 0.35: 95% CI 0.14, 0.56) and the far‐equator subgroup (MD 0.23: 95% CI 0.00, 0.46). The forest plot is shown in Figure S6.

Preoperative versus Postoperative Serum Calcium Level

Eleven included studies,,,,,,,,,,that provided serum calcium levels before and after surgery for a total of 964 participants. The meta‐analysis of the pooled data showed that both the intervention and control groups had significantly lower postoperative calcium levels in 48 h than in the preoperative period; Intervention (MD, −0.61 mg/dL; 95% CI, −0.78 to −0.43); Control (MD, −0.84 mg/dL; 95% CI, −1.06 to −0.62). However, there was no significant difference between the intervention group compared with the control group (p ‐value = 0.10). The forest plot is shown in Figure 6.

Fig. 6 
Preoperative versus postoperative serum calcium level. [Color figure can be viewed in the online issue, which is available at.]

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^193a0029]. The British Journal of Surgery (2025). High credibility.

Post-thyroidectomy hypoparathyroidism—supplement use reporting (Statement 14) states that short-term postoperative follow-up data should also include the use of calcium supplementation, specifying routine versus selective and oral use only versus intravenous, as well as vitamin D or active vitamin D analogue prescription; the document records Consensus: Yes with Evidence level: Moderate.

---

### Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines [^91625a2a]. British Journal of Anaesthesia (2011). Low credibility.

Recommendations

Detection of anaemia

Recommendation 1 : We recommend that elective surgical patients have an Hb level determination as close to 28 days before the scheduled surgical procedure as possible (Grade 1C).

The Circular of Information for Blood and Blood Productshas recommended that iron, vitamin B 12, folic acid, and erythropoietin be used instead of blood transfusion, ‘if the clinical condition of the patient permits sufficient time for those agents to promote erythropoiesis …’ The key phrase relevant to this recommendation is, ‘sufficient time … to promote erythropoiesis.’ Detection of anaemia as close to 28 days before surgery is recommended for sufficient time for evaluation and management.

Recommendation 2 : We suggest that the patient's target Hb before elective surgery be within the normal range (female ≥12 g dl −1, male ≥13 g dl −1), according to the WHO criteria (Grade 2C).

This recommendation is a suggestion, indicating a lack of panel consensus and evidence on whether elective surgical procedures should be cancelled, representing best practices, for patients who are identified to be anaemic. Delay of elective scheduled surgery for definitive evaluation of newly detected anaemia and associated clinical conditions (nutritional deficiency, chronic renal disease, etc.) will benefit patients and reduce harm, including likelihood of exposure to blood transfusions.

---

### Mineral / vitamin supplement (nephron FA) [^3d5a4363]. FDA (2021). Medium credibility.

Suggested Dosage

One tablet daily taken away from meals, or as directed by the physician.

---

### American Thyroid Association statement on outpatient thyroidectomy [^bb0deea6]. Thyroid (2013). Medium credibility.

Calcium management after total thyroidectomy—Significant temporary hypocalcemia may occur in up to 25% of patients following total thyroidectomy, usually manifesting 48–72 hours after surgery, and postoperative parathyroid hormone (PTH) levels have been utilized to facilitate prompt (same-day or 23-hour) discharge. A measurement taken in the recovery room 1–2 hours after surgery has been described as informative, and with or without the addition of calcitriol 0.5–1 mcg daily, oral regimens are used. Oral calcitriol (0.25 mcg per oral twice or thrice daily) can be added in patients with low postoperative PTH levels (<15 pg/mL). Routine calcium monitoring may be helpful, and given the delayed action of these oral agents (1–2 hours), dosing may begin immediately upon the discovery of mild symptoms.

---

### The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism [^42b3dc14]. JAMA Surgery (2016). Medium credibility.

Regarding nonpharmacologic interventions for primary hyperparathyroidism, more specifically with respect to vitamin D and calcium supplementation, AAES 2016 guidelines recommend to initiate vitamin D supplementation in patients with vitamin D deficiency after apparently successful parathyroidectomy.

---

### American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery [^1b5d1d3f]. Thyroid (2012). Medium credibility.

After thyroidectomy initial care plan—communication priorities: Regardless of who will be providing immediate care and long‑term surveillance for patients with thyroid cancer, communication about the operative course is essential, and if all caregivers are using a common electronic medical record, such communication is especially easy to do. Most multidisciplinary collaborators appreciate knowing the particular or possible complications of thyroidectomy that may delay recovery, there is increasing demand to engage the patient in direct perioperative communication, and the surgeon’s instructions and plan for prophylactic or therapeutic calcium supplementation, wound care, drain management, voice changes, calcitriol use, pending medication changes, and pending lab testing including TSH monitoring and return to work are highlighted for communication.

---

### Near-infrared autofluorescence for parathyroid detection during endocrine neck surgery: a randomized clinical trial [^9bb7277e]. JAMA Surgery (2025). High credibility.

Outcomes

The study’s primary objective is to compare the average number of PGs identified with high confidence per patient with and without NIRAF. As outlined in the eTable in Supplement 1, a normalization method was used to account for instances where PGs were missing.

Secondary outcomes include transient (at 24-48 hours after surgery) and last follow-up (beyond 24-48 hours) hypoparathyroidism rates, defined as PTH less than the normal institutional range. After thyroidectomy, follow-up was not required if the initial postoperative PTH was normal and the patient was not taking calcium supplements or activated vitamin D. Real-world follow-up patterns varied (Figure 1). Therefore, the latest PTH was used to determine postsurgical hypoparathyroidism. Other outcomes include operative duration, number of FS (including fine-needle aspirations), autotransplant rates, and inadvertent PG resection (defined by histology confirmed whole/fragment in thyroid specimen).

Figure 1. 
Trial Flowchart

Other data collected includes age, sex, race, ethnicity, body mass index, diagnosis, surgical approach, length of stay, laboratory values (PTH, serum calcium, 25-OH vitamin D), and devascularized PGs, as noted by the surgeon. Additionally, for parathyroidectomy, intraoperative PTH drop (more than 50% drop from baseline at 10 minutes postresection) and rate of failure (calcium more than upper limit of normal at the participating center at the last follow-up) were collected.

Statistical Analysis

Sample size for a 95% powered trial was 33 patients per group using t test, calculated using a previous NIRAF-based PG identification study.Assuming a 30% dropout rate, the trial was designed to enroll 80 patients (40 NIRAF and 40 control) per surgeon per arm, resulting in a target of 400 patients per arm.

Baseline, intraoperative, and postoperative statistics are reported separately for the NIRAF and control groups. Continuous variables are expressed as means and medians with SDs and IQRs and analyzed using the Welch t test with their 95% CIs. Categorical variables are presented as frequencies and percentages, and significance assessed via 1-sided χ 2 or Fisher exact tests. A paired t test was used in a subanalysis of the NIRAF group. P values <.05 were considered significant. The data were analyzed using R version 4.2.3 (The R Project).

---

### Executive summary: perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline [^d6a00d37]. Chest (2022). High credibility.

Regarding perioperative care for perioperative bleeding, more specifically with respect to management of antithrombotic therapy, VKAs, ACCP 2022 guidelines recommend to avoid administering routine preoperative vitamin K in patients requiring VKA interruption for an elective surgery/procedure having an elevated INR (> 1.5) -2 days before surgery/procedure.

---

### American Society of Plastic Surgeons evidence-based clinical practice guideline revision: reduction mammaplasty [^63d847be]. Plastic and Reconstructive Surgery (2022). High credibility.

Reduction mammaplasty—chronic corticosteroid use: Chronic corticosteroid use might be mitigated by discontinuance of the medication preoperatively and supplementation with vitamin A perioperatively, but there is a lack of evidence for this.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^bf940b50]. The Laryngoscope (2025). Medium credibility.

Mean postoperative calcium level: Intervention versus controls

There were 10 included studies,,,,,,,,,that provided postoperative serum calcium as outcomes for a total of 964 participants. The meta‐analysis of the pooled data showed that the preoperative supplement groups had significantly higher postoperative calcium levels than the control group (MD, 0.30 mg/dL: 95% CI, 0.15 to 0.44). The forest plot (Fig. S2) reveals substantial heterogeneity (I 2 = 83%).

The sensitivity analysis of the studies,,,with no additional adjunct therapy during the perioperative period also demonstrated the significantly higher mean postoperative calcium level in the preoperative supplement groups (MD, 0.11 mg/dL: 95% CI, 0.05 to 0.16) without significant heterogeneity (I 2 = 10%). The forest plot is in Figure S2.

Postoperative serum hypocalcemia (serum Ca ≤8.5 mg/dL) within 48 h

There were 13 included studies,,,,,,,,,,,,that provided the rate of postoperative hypocalcemia as a result for a total of 1405 participants. Meta‐analysis of the pooled data showed that the preoperative supplement groups had a significantly reduced postoperative hypocalcemia rate within 48 h compared with the control group (OR, 0.41; 95% CI, 0.27 to 0.62). The forest plot (Fig. 3) shows substantial heterogeneity (I 2 = 65%).

Fig. 3 
Postoperative serum hypocalcemia in 48 h: Intervention versus controls. [Color figure can be viewed in the online issue, which is available at.]

Postoperative symptomatic hypocalcemia (serum Ca ≤8.5 mg/dL with hypocalcemic symptoms) prior to discharge

There were 11 included studies,,,,,,,,,,that provided the rate of postoperative symptomatic hypocalcemia prior to discharge as outcomes for a total of 1114 participants. The meta‐analysis of the pooled data showed that the intervention groups had a significantly lower rate of postoperative symptomatic hypocalcemia compared with the control group (OR, 0.38; 95% CI, 0.24 to 0.62). The forest plot (Fig. 4) shows moderate significant heterogeneity (I 2 = 47%).

Fig. 4 
Postoperative symptomatic hypocalcemia before discharge: Intervention versus controls. [Color figure can be viewed in the online issue, which is available at.]

---

### Dry eye syndrome preferred practice pattern ® [^ffbfb0e2]. Ophthalmology (2024). High credibility.

Dry eye syndrome—associated conditions and nonocular symptoms: Listed associated factors include trauma, chronic viral infections, nonocular surgery, orbital radiation, neurological conditions, diet/nutrition issues, and gastrointestinal surgical history, with examples such as mechanical, chemical, or thermal trauma; hepatitis C and HIV; bone-marrow transplant, head and neck surgery, and trigeminal neuralgia surgery; Parkinson disease, Bell’s palsy, Riley-Day syndrome, and trigeminal neuralgia; vitamin A deficiency and severely limited diet in patients with autism spectrum disorder; and gastric bypass and pancreatic surgery. Nonocular symptoms include dry mouth, dental cavities, oral ulcers, fatigue, joint pain/muscle ache, and menopause.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^114155b6]. The British Journal of Surgery (2025). High credibility.

Post-thyroidectomy hypoparathyroidism—management when PTH is undetectable: Undetectable PTH serum level within 24 h after thyroid surgery may increase the risk of permanent parathyroid dysfunction and these patients require immediate onset of supplementation with calcium and an active vitamin D analogue and further close follow-up (evidence level: Moderate).

---

### American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults [^f7747f23]. Thyroid (2018). Medium credibility.

American Thyroid Association postoperative hypoparathyroidism—risk factors, thresholds, and management are summarized as follows: Hypoparathyroidism occurs when a low intact parathyroid hormone (PTH) level is accompanied by hypocalcemia. Risk factors for post-thyroidectomy hypoparathyroidism include bilateral thyroid operations, autoimmune thyroid disease, central neck dissection, substernal goiter, surgeon inexperience, and malabsorptive conditions. Measurement of intraoperative or early postoperative PTH levels following thyroidectomy can help guide patient management, and in general, a postoperative PTH level ≤15 pg/mL indicates increased risk for acute hypoparathyroidism. Effective management of mild to moderate potential or actual postoperative hypoparathyroidism can be achieved by administering either empiric/prophylactic oral calcium and vitamin D, selective oral calcium and vitamin D based on rapid postoperative PTH level(s), or serial serum calcium levels as a guide for supplementation; for more severe hypocalcemia, inpatient management may be necessary. Permanent hypoparathyroidism has long-term consequences for both objective and subjective well-being, and should be prevented whenever possible.

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^19c0f885]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

Vitamin D and Calcium Prescribing and Management Patterns

Twelve (22.6%) sites reported having a comprehensive care pathway or protocol to follow for each patient presenting to hospital with a fragility fracture. Comprehensive pathways, such as Fracture Liaison Services,included prescribing/recommending calcium and vitamin D to each patient as well as a plan of referral and/or investigation and patient education. Two of these sites (34 included patients) are Fracture Liaison Services. Twelve (22.6%) sites reported having a noncomprehensive protocol to follow for patients with fragility fracture. These noncomprehensive strategies included only prescribing/recommending calcium and vitamin D or only referring patients with fragility fracture to a specialist or following a protocol inconsistently or on a case-by-case basis. Twenty-nine (54.7%) sites reported that they do not follow a standardized protocol or their fragility fracture management procedure is unknown (Table 4). Vitamin D was prescribed/recommended to 456 fragility fracture patients (456/603, 75.6%) at the postoperative visit, while calcium was prescribed/recommended to 435 fragility fracture patients (435/603, 72.1%) at the postoperative visit (Table 1).

Table 4. 
Clinical Site Characteristics.

---

### American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults [^973da749]. Thyroid (2018). Low credibility.

Background

Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association Surgical Affairs Committee Statement is to provide an overview of its diagnosis, prevention, and treatment.

Summary

HypoPT occurs when a low intact parathyroid hormone (PTH) level is accompanied by hypocalcemia. Risk factors for post-thyroidectomy hypoPT include bilateral thyroid operations, autoimmune thyroid disease, central neck dissection, substernal goiter, surgeon inexperience, and malabsorptive conditions. Medical and surgical strategies to minimize perioperative hypoPT include optimizing vitamin D levels, preserving parathyroid blood supply, and autotransplanting ischemic parathyroid glands. Measurement of intraoperative or early postoperative intact PTH levels following thyroidectomy can help guide patient management. In general, a postoperative PTH level <15pg/mL indicates increased risk for acute hypoPT. Effective management of mild to moderate potential or actual postoperative hypoPT can be achieved by administering either empiric/prophylactic oral calcium and vitamin D, selective oral calcium, and vitamin D based on rapid postoperative PTH level(s), or serial serum calcium levels as a guide. Monitoring for rebound hypercalcemia is necessary to avoid metabolic and renal complications. For more severe hypocalcemia, inpatient management may be necessary. Permanent hypoPT has long-term consequences for both objective and subjective well-being, and should be prevented whenever possible.

---

### Preoperative vitamin D supplementation to reduce hypocalcemia following total thyroidectomy: systematic review and meta-analysis of randomized clinical trials [^a05174c0]. Head & Neck (2025). Medium credibility.

Objective

This study aims to determine whether preoperative supplementation of vitamin D reduces the incidence of hypocalcemia following total thyroidectomy.

Methods

Conducted in conformity with the PRISMA statement, a systematic review and meta-analysis of randomized clinical trials (RCT) was performed assessing postoperative hypocalcemia and postoperative symptomatic hypocalcemia.

Results

The search strategy yielded 3808 potentially relevant publications, with eight RCTs ultimately included. These eight trials included a total of 902 patients (22.73% male, n=205/902), with a median age of 48.9years (95% CI, 43.5-53.5). Four trials administered only vitamin D in the interventional arm, three trials administered both calcium and vitamin D in the interventional arm, and one trial administered vitamin D in the interventional arm and calcium in both arms. Pooled results from the eight included trials showed a reduced risk of postoperative hypocalcemia in the intervention arm (RR, 0.77; 95% CI, 0.62-0.96; p=0.02). When excluding the studies that administered calcium supplements in addition to vitamin D, the pooled results showed a similar reduced risk of postoperative hypocalcemia (RR, 0.74; 95% CI, 0.57-0.96; p=0.03). Analysis of six trials reporting the incidence of postoperative symptomatic hypocalcemia (n=564) showed a reduced risk in the vitamin D arm, with or without calcium, compared to the control arm (RR, 0.56; 95% CI, 0.34-0.93; p=0.023).

Conclusions

Our findings suggest that preoperative vitamin D administration, with or without calcium carbonate, significantly reduces the risk of postoperative hypocalcemia and symptomatic hypocalcemia in patients undergoing total thyroidectomy.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^f3895828]. The Laryngoscope (2025). Medium credibility.

INTRODUCTION

Thyroid neoplasms account for approximately 95% of all endocrine tumors.Thyroid surgery is indicated for thyroid cancer and some benign thyroid diseases. One of the most prevalent complications of complete thyroidectomy is postoperative hypocalcemia. Following total thyroid surgery, the incidence of asymptomatic and symptomatic hypocalcemia was found to be 13% to 49% in the first 24 ho and 63.6% within 48 h.Some patients have transient hypocalcemia that resolves on its own after the parathyroid function is restored, but others have long‐term hypocalcemia that can last for more than 6 months, a year, or a lifetime and requires treatment.

Many randomized controlled trials (RCTs) suggest that preoperative vitamin D insufficiency is a substantial risk factor for hypocalcemia after thyroidectomy.,Various studies revealed that preoperative vitamin D deficiencies and insufficiencies (VDD) affect around 30% to 50% of the population worldwide, and this number is increasing.

Postoperative hypocalcemia can manifest as asymptomatic hypocalcemia, mild symptomatic hypocalcemia, or severe symptomatic hypocalcemia. Patients with mild symptoms usually present with perioral paresthesia, tingling sensations, or carpopedal tetany, which can be managed with calcium and vitamin D supplements administered orally. Patients with serious life‐threatening symptoms caused by acute severe hypocalcemia, such as laryngospasm, seizures, unconsciousness, or cardiac arrhythmias, must be treated as soon as possible with intravenous calcium supplementation. Some of them, however, may have experienced refractory hypocalcemia, which prolonged their hospitalization.

RCTs on routine post‐total thyroidectomy calcium and vitamin D administration have shown benefits, including lessening the incidence of postoperative hypocalcemia and shortening the hospital stay.Even with a prescription for a routine postoperative supplement, some patients could still experience serum hypocalcemia after surgery, so preoperative supplement regimens were proposed. There were many studies that evaluated the role of preoperative calcium and vitamin D supplements, but the results were still controversial.

The objective of this systematic review and meta‐analysis was to evaluate the role of preoperative calcium and/or vitamin D supplementation in patients who underwent total thyroidectomy. We hypothesized that preoperative calcium and/or vitamin D administration would reduce the incidence and severity of post‐total thyroidectomy hypocalcemia.

---

### Vitamins and mineral (diatrol) [^138fe6e5]. FDA (2024). Medium credibility.

DOSAGE AND ADMINISTRATION

Take one (1) caplet daily or as directed by a licensed healthcare practitioner.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^3394e361]. The British Journal of Surgery (2025). High credibility.

Standardized surgical core variables after thyroidectomy—Statement 9 specifies that this minimum set should include baseline parameters and operative details, including patient characteristics; disease characteristics; type and extent of thyroid surgery; intraoperative number of parathyroid glands identified and preservation technique(s) including intraoperative autotransplantation, and adjuncts used; intraoperative events; postoperative treatment for hypocalcaemia; supplementation with calcium and/or vitamin D/active vitamin D analogue; time and date of surgery; and final pathology report.

---

### Salivary gland hypofunction and / or xerostomia induced by nonsurgical cancer therapies: ISOO / MASCC / ASCO guideline [^b8fa990e]. Journal of Clinical Oncology (2021). High credibility.

Radiation therapy—vitamin E and antioxidants should be avoided during head and neck cancer therapy, as randomized data demonstrated an adverse impact of antioxidant therapy on cancer-related outcomes; patients should be counseled against use of supplemental antioxidants, and the evidence base provides enough data to recommend against the use of antioxidants.

---

### Phase II randomized study of preoperative calcitriol to prevent hypocalcemia following thyroidectomy [^632a91e8]. Head & Neck (2021). Medium credibility.

Background

A prospective, stratified, randomized, double-blind, placebo-controlled study was conducted to observe the impact of preoperative calcitriol supplementation on serum calcium levels following total thyroidectomy.

Methods

Subjects were randomized 1:1 to receive 1μg calcitriol or placebo for 1 week preceding thyroidectomy. The primary outcome measure was change in serum calcium from baseline to 18h post-thyroidectomy. Subjects were also assessed for incidence of symptomatic hypocalcemia, length of stay, readmission for hypocalcemia, and intravenous calcium supplementation.

Results

Forty-seven patients underwent thyroidectomy; 23 received preoperative calcitriol supplementation, and 24 received placebo. Repeated measures regression demonstrated no difference in postoperative serum calcium over time (p =0.22). There were no occurrences of hypocalcemia, intravenous calcium supplementation, or readmission in either group. No difference was observed in length of stay (p =0.38). One patient in the calcitriol group developed Grade 3 hypercalcemia.

Conclusions

Preoperative calcitriol supplementation had no impact on postoperative serum calcium levels compared to placebo.

---

### Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism [^a5cb0b82]. The Cochrane Database of Systematic Reviews (2019). Medium credibility.

Background

Post-surgical hypoparathyroidism is a common complication after thyroid surgery. The incidence is likely to increase given the rising trend in the annual number of thyroid operations being performed. Measures to prevent post-thyroidectomy hypoparathyroidism including different surgical techniques and prophylactic calcium and vitamin D supplements have been extensively studied. The management of post-thyroidectomy hypoparathyroidism however has not been extensively evaluated. Routine use of calcium and vitamin D supplements in the postoperative period may reduce the risk of symptoms, temporary hypocalcaemia and hospital stay. However, this may lead to overtreatment and has no effect on long-term hypoparathyroidism. Current recommendations on the management of post-thyroidectomy hypoparathyroidism is based on low-quality evidence. Existing guidelines do not often distinguish between surgical and non-surgical hypoparathyroidism, and transient and long-term disease.The aim of this systematic review was to summarise evidence on the use of calcium, vitamin D and recombinant parathyroid hormone in the management of post-thyroidectomy hypoparathyroidism. In addition, we aimed to highlight deficiencies in the current literature and stimulate further work in this field.

Objectives

The objective of this systematic review was to assess the effects of calcium, vitamin D and recombinant parathyroid hormone in managing post-thyroidectomy hypoparathyroidism.

Search Methods

We searched CENTRAL, MEDLINE, PubMed, Embase as well as ICTRP Search Portal and ClinicalTrials.gov. The date of the last search for all databases was 17 December 2018 (except Embase, which was last searched on 21 December 2017). No language restrictions were applied.

Selection Criteria

We planned to include randomised control trials (RCTs) or controlled clinical trials (CCTs) examining the effects of calcium, vitamin D or recombinant parathyroid hormone in people with temporary and long-term post-thyroidectomy hypoparathyroidism.

Data Collection and Analysis

Two review authors independently screened titles, abstracts and full texts for relevance.

Main Results

Database searches yielded a total of 1751 records. We retrieved potentially relevant full texts and excluded articles on the following basis: not a RCT or CCT; intervention, comparator or both did not match prespecified criteria; non-surgical causes of hypoparathyroidism, and studies on prevention. None of the articles was eligible for inclusion in the systematic review.

Authors' Conclusions

This systematic review highlights a gap in the current literature and the lack of high-quality evidence in the management of post-thyroidectomy temporary and long-term hypoparathyroidism. Further research focusing on clinically relevant outcomes is needed to examine the effects of current treatments in the management of temporary and long-term post-thyroidectomy hypocalcaemia.

---

### A guide to perioperative nutrition [^bf97687c]. Aesthetic Surgery Journal (2009). Low credibility.

According to the author, nutritional supplementation in the period before and after surgery can have a significant impact on surgical outcome by reducing bruising, swelling, and inflammation; promoting wound healing; enhancing immunity; and reducing oxidation generated by surgery and anesthetic agents. However, supplements must be administered judiciously; some popular herbal products are contraindicated before and after surgery.

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS) on pediatric benign and malignant Thyroid surgery [^d67503c2]. Endocrine Practice (2021). High credibility.

Laboratory evaluation for children undergoing thyroid surgery—tests to obtain: Laboratory evaluation of children undergoing thyroid surgery should include thyroid stimulating hormone (TSH), free thyroxine, thyroid autoantibodies, and a panel that includes calcium, albumin, phosphorus, and magnesium, as well as 25-hydroxy vitamin D and intact parathyroid hormone in cases of total or completion thyroidectomy. Free or total triiodothyronine may be ordered with a suppressed TSH, and thyroid function testing is ideally drawn before FNA to determine if the nodule is hyperfunctional.

---

### Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study [^e732065c]. BMJ (2012). Excellent credibility.

Data collection

Local investigators and staff received handouts and training to become familiar with data collection and procedures for monitoring surgical complications. After each thyroidectomy, the surgeon would systematically complete a patient report form, which included items regarding surgical indication and procedures, and the number of interventions that the surgeon had undertaken that day. Clinical research assistants completed data collection using medical records. These data included patient demographics and information on previous thyroid surgeries, thyroid specimen weights, postoperative supplementation with calcium or vitamin D (or both), calcium assay values, and assessments of vocal cord mobility.

Surgeons also completed individual questionnaires regarding their demographics, previous background, and professional experience, using a one off survey. The surgeon’s length of experience was measured as the number of years spent in practice since graduation (that is, the end of residency). Before the analysis, we separated the experience variable into four categories to depict the successive steps in a surgeon’s career in France: less than 2 years (that is, a very young surgeon starting a surgical fellowship), 2 to 4 years (junior surgeon ending a surgical fellowship), 5 to 19 years (senior surgeon), and 20 years and over (very experienced surgeon at the head of a surgical department).

We obtained the structural characteristics of each participating hospital from the French annual statistics on healthcare facilities in 2008.We calculated the proportion of cases included in the study as the ratio of the number of thyroidectomies with a fully completed patient form to the number of eligible thyroidectomies recorded in the hospital administrative databases.

Ethical considerations

The Research Committee for the Protection of Persons allowed the study in accordance with ethical directives. The National Advisory Committee on Information Processing in Material Research in the Field of Health also approved the study, regarding the anonymous processing of personal health information. The participating centres approved the study protocol without giving incentives to surgeons for their participation. Before surgery, patients received written information about personal data use, and gave verbal consent for sharing their data.

---

### The role of topical vitamin A in promoting healing in surface refractive procedures: a prospective randomized controlled study [^c39f07fd]. Clinical Ophthalmology (2013). Low credibility.

Statistical analysis

Statistical analysis was performed using the Statistical Package for the Social Sciences version 13.0 (SPSS version 13.0; SPSS Inc. Chicago, IL, USA). The Student’s t -test for unpaired data was used to compare all parameters between the two groups. A chi-square test was used to compare the association between categorical variables. P -values < 0.05 were considered statistically significant.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^4c2bd012]. The British Journal of Surgery (2025). High credibility.

Definitions—temporary and permanent postoperative hypoparathyroidism: Temporary postoperative hypoparathyroidism is a condition that usually resolves within the first 6 months after surgery (but sometimes can last up to 12 months) with PTH and serum calcium levels within the reference range, without calcium and/or active vitamin D analogue supplements. Permanent postoperative hypoparathyroidism is a condition that continues for more than 12 months after surgery with persistently low serum calcium levels if not supplemented; the PTH level can be undetectable, low, or inappropriately low, and to assure the diagnosis of this condition, there should be an attempt at stopping supplements within 12 months after surgery.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^42771bc4]. The British Journal of Surgery (2025). High credibility.

Baseline patient characteristics—minimum surgical core variables should include the following parameters as stated: Sex; Preoperative serum calcium level; Preoperative 25-OH vitamin D level; Preoperative supplementation with calcium and/or vitamin D; History of thyroid/parathyroid surgery; History of bariatric surgery; and History of gastrointestinal malabsorption syndrome, with listed evidence levels as Moderate or Low; Race and ethnicity and BMI are listed but show Consensus: No; GA voting is presented as Agree: 59.72%, Disagree: 40.28%.

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS) on pediatric benign and malignant Thyroid surgery [^3a6a44ad]. Endocrine Practice (2021). High credibility.

Hypocalcemia after total thyroidectomy—hypocalcemia is the most common complication after total thyroidectomy and can result in prolonged hospital admission; management involves providing temporary or permanent calcium and calcitriol supplementation as well as the monitoring of symptoms and serum calcium levels, and postoperative hypocalcemia can be managed in anticipation or with the assistance of intraoperative parathyroid hormone monitoring.

---

### American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery [^09573167]. Thyroid (2012). Medium credibility.

Thyroid cancer surgery—preoperative and intraoperative information for postoperative management is acquired in three distinct settings (preoperative evaluations, intraoperative findings, and postoperative data, events, and plans) and may significantly influence decision-making with regard to the role of adjuvant radioactive iodine therapy (RAI), degree of thyrotropin (TSH) suppression, and extent and frequency of follow-up evaluations. Potentially important preoperative findings include high-risk physical examination findings such as a palpable cervical lymph node, a cervical or upper thoracic scar, fixation or other evidence of gross extrathyroidal extension, hoarseness, stridor, morbid obesity, and dermal metastasis; high-risk historical features such as prior neck irradiation, unexplained bone pain, suspicion of distant or central nervous system metastasis, current or prior hyperparathyroidism, multiple endocrine neoplasia type 2, prior difficult intubation, and chronic vitamin D deficiency; preoperative ultrasound findings with regard to both the thyroid gland and cervical lymph node evaluation; performance of any imaging studies using iodinated contrast within the previous 6 months; comorbid conditions, including pregnancy, that could influence decisions regarding TSH suppression, thyroid hormone withdrawal, or use of RAI; and abnormal laboratory values that could influence RAI decision-making such as alterations in renal function or in the complete blood count and differential. Intraoperative information critical to the risk stratified postoperative management approach includes extent of thyroid surgery, description of gross extrathyroidal extension, completeness of surgical resection (R0, R1, or gross residual disease), details of suspected residual gross or microscopic thyroid tissue, extent of lymph node surgery performed, recurrent laryngeal nerve issues, and parathyroid gland issues.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^4639f894]. The British Journal of Surgery (2025). Medium credibility.

Statement 1: Biochemical postoperative hypoparathyroidism is defined by an undetectable or low PTH (less than the lower limit of the centre-specific reference range) with or without hypocalcaemia.

Consensus: Yes (8.088)

Outliers: 8

Negative outliers: 2

Evidence level: Moderate

A systematic review and meta-analysis recently analysed 188 studies on the definition and early diagnosis of hypoparathyroidism; it found that postoperative PTH measurements within 24 h had higher sensitivity and specificity than intraoperative PTH for predicting hypoparathyroidism, thresholds of <10 pg/ml and <15 pg/ml were both reliable for identifying patients at risk, no specific time point within the first 24 h (for example 1 h, 6 h versus 12 h versus 24 h) was superior, and any measurement within postoperative day 1 (POD1) was effective. Nowadays, measuring PTH within 24 h is considered standard practice in many endocrine surgery centres. It allows for early identification of patients at risk of hypoparathyroidism, timely initiation of calcium and/or vitamin D supplementation, and safe discharge for individuals at low risk of hypoparathyroidism. This timing is also used in registry protocols and quality improvement initiatives to benchmark outcomes. In addition, measuring serum PTH levels 1–6 h after total or completion thyroidectomy provides high predictive accuracy for identifying the need for supplementation to prevent symptoms that may require readmission. This approach enables selective supplementation and supports safe early discharge, particularly in outpatient thyroidectomy protocols where timely discharge decisions are critical,.

Statement 2: The first postoperative PTH level should be measured within 24 h.

Consensus: Yes (8.022)

Outliers: 9

Negative outliers: 8

Evidence level: Moderate

GA voting: Agree: 78.25%, Disagree: 21.75%. In addition, 66.78% of voters preferred this measurement to be done 1–6 h after surgery.

Hypoparathyroidism is a clinically heterogeneous condition, where biochemical markers like PTH and calcium are essential for diagnosis, but symptom severity varies widely and may not align with laboratory values,.

Statement 3: Postoperative hypoparathyroidism may be an asymptomatic condition or it can become clinically apparent with a variety of manifestations ranging from mild numbness and tingling, muscle cramps, tetany, and seizures to life-threatening laryngospasm and cardiac arrhythmia.

---

### A missed opportunity in bone health: vitamin D and calcium use in elderly femoral neck fracture patients following arthroplasty [^584bde50]. Geriatric Orthopaedic Surgery & Rehabilitation (2017). Low credibility.

Results

Patient Demographics

Of the 824 HEALTH participants who had reached their 12-month visit, 603 were included in this analysis. We excluded data from the 100 patients who had died prior to their 12-month visit and the 121 participants who did not have at least 3 postoperative visits. The mean age of the study participants was 78.6 years (standard deviation: 8.8), and most participants were female (73.1%). The majority of patients were enrolled at clinical sites in North America (244, 40.5%) and Europe (325, 53.9%; Table 1).

Table 1. 
Patient Demographics.

Vitamin D and Calcium Supplementation

Two-hundred nine (34.7%) patients reported never taking vitamin D within the first 12 months after surgery, 158 (26.2%) reported taking vitamin D inconsistently, and 236 (39.1%) reported taking vitamin D consistently (Table 2). Two hundred seventeen (36.0%) patients reported never taking calcium within the first 12 months after surgery, 171 (28.4%) reported taking calcium inconsistently, and 215 (35.7%) reported taking calcium consistently (Table 2). Vitamin D and calcium use consistency was highly correlated (Spearman ρ:.861; P <.001). There were 197 (32.7%) participants who consistently used both calcium and vitamin D and 194 (32.2%) participants who consistently did not use calcium nor vitamin D.

Table 2. 
Consistency of Vitamin D and Calcium Use.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^4b788bac]. The British Journal of Surgery (2025). High credibility.

Post-thyroidectomy hypoparathyroidism—preoperative data to report: Some preoperative parameters like 25-OH vitamin D serum level and PTH serum level should be reported when possible and available (evidence level: Moderate).

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^3aa03a38]. The British Journal of Surgery (2025). High credibility.

Post-thyroidectomy hypoparathyroidism—postoperative follow-up data to report: Some postoperative follow-up data including inadvertent excision of parathyroid gland(s) confirmed by histology, PTH serum level within 24 h of the operation, need for intravenous calcium, visit(s) to the emergency department, and readmission(s) for hypoparathyroidism, and use of calcium/vitamin D supplements during early (6 weeks), and long-term (12 months) follow-up should be reported (evidence level: Moderate).

---

### Consensus statement by the American association of clinical endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS-ES) on pediatric benign and malignant thyroid surgery [^ce339616]. Head & Neck (2021). High credibility.

AACE/AHNS-ES pediatric thyroid surgery—Hypocalcemia after thyroidectomy: Hypocalcemia is the most common complication after total thyroidectomy and can result in prolonged hospital admission. Management starts with the anticipation of the complication and involves providing temporary or permanent calcium and calcitriol supplementation as well as the monitoring of symptoms and serum calcium levels; operative vigilance should be maintained for parathyroid glands, which are smaller in children, and postoperative hypocalcemia can be managed in anticipation or with the assistance of intraoperative parathyroid hormone monitoring.

---

### Preoperative calcium or vitamin D supplement in thyroidectomy: a systematic review and meta-analysis [^871c2234]. The Laryngoscope (2025). Medium credibility.

Preoperative supplementation versus combined preoperative and postoperative supplementation

A subgroup analysis was performed using preoperative supplementation versus combined preoperative and postoperative supplementation according to 10 included studies comparing mean postoperative calcium levels,,,,,,,,,; A total of 13 included articles comparing postoperative hypocalcemia rates in 48 h,,,,,,,,,,,,; and 11 included studies comparing postoperative symptomatic hypocalcemia rates.,,,,,,,,

The results showed that the intervention group had a higher mean postoperative calcium level than the control group for only the combined preoperative and postoperative supplementation subgroups. Both subgroups had a significantly reduced rate of postoperative symptomatic hypocalcemia and a lower rate of postoperative hypocalcemia at 48 h compared with the control group.

There was no significant difference (P = 0.53; 0.17; 0.08) between the preoperative supplementation subgroup (MD 0.63: 95% CI ‐0.50, 1.75); (OR 0.57; 95% CI 0.33, 0.96); (OR 0.42: 95% CI 0.17, 1.00) and the combined preoperative and postoperative supplementation subgroup (MD 0.27: 95% CI 0.14, 0.40); (OR 0.32; 95% CI 0.17, 0.60); (OR 0.36: 95% CI 0.20, 0.66) according to the mean postoperative calcium level, the postoperative hypocalcemia at 48 h, and the postoperative symptomatic hypocalcemia accordingly. The forest plot is shown in Figure 5.

Fig. 5 
Mean postoperative calcium level: subgroup analysis of preoperative supplementation versus combined preoperative and postoperative supplementation. [Color figure can be viewed in the online issue, which is available at.]

The sensitivity analysis comparing the combined preoperative and postoperative supplementations versus postoperative supplementations demonstrated significant results favoring the combined preoperative and postoperative supplementations in all outcomes.

---

### American Society of Plastic Surgeons evidence-based clinical practice guideline revision: reduction mammaplasty [^b410bbac]. Plastic and Reconstructive Surgery (2022). High credibility.

American Society of Plastic Surgeons reduction mammaplasty—Recommendation 2 reports aggregate evidence quality Moderate and strength of recommendation Moderate; benefits include appropriately set expectations, obtaining a detail-specific informed consent, patient awareness of risk, that obese patients may want to lose weight before surgery to reduce risks, and consultation to determine whether discontinuation of corticosteroids is possible and/or recommending supplemental vitamin A to mitigate risk. Risk, harm, cost notes that a patient with one or more of these risk factors may be discouraged from surgical treatment, and thus suffer ongoing symptomatology related to breast hypertrophy. Benefit–harm assessment is Preponderance of benefit, and value judgments, intentional vagueness, role of patient preferences, exclusions, and differences of opinion are None.

---

### Salivary gland hypofunction and / or xerostomia induced by nonsurgical cancer therapies: ISOO / MASCC / ASCO guideline [^9f148d7d]. Journal of Clinical Oncology (2021). High credibility.

Vitamin E and antioxidant supplementation during radiation therapy in head and neck cancer—two RCTs did not show preventive benefit for acute xerostomia or salivary gland hypofunction, although one trial reported improvement of xerostomia from 1 to 6 months after therapy; randomized data have demonstrated an adverse impact of antioxidant therapy on cancer-related outcomes.

---

### The critical role of nutrition in facial plastic surgery [^ec5f0e46]. Facial Plastic Surgery Clinics of North America (2019). Medium credibility.

Nutrition plays a key role in optimizing healing following surgery. The increased catabolic state postoperatively, coupled with a propensity for patients to be suffering from marginal nutritional deficiencies at baseline preoperatively, necessitates that the surgeon be attuned to the need for optimal perioperative nutritional support. This ensures the smoothest recovery and best possible outcomes in facial plastic surgery. Key nutrients include vitamin A, vitamin C, zinc, bromelain, arnica montana, arginine, glutamine, hydrolyzed collagen, vitamin B complex, and protein. The ability for patients to obtain this optimal supplementation in a single product is the ideal solution for both surgeon and patient.

---

### Preoperative bone health assessment and optimization in spine surgery [^273a7bd8]. Neurosurgical Focus (2020). Medium credibility.

Objective

The purpose of this investigation was to characterize the bone health in preoperative spine surgery patients. This information will provide a framework to understand the needs and methods for providing bone health optimization in elective spine surgery patients.

Methods

A retrospective study of 104 patients undergoing bone health optimization was performed. Patients were selected based on risk factors identified by the surgeon and suspected compromised bone health. Evaluation included history and examination, laboratory investigations, and bone mineral density (BMD) at 3 sites (femoral neck, lumbar spine, and radius). Patients' bone status was classified using WHO criteria and expanded criteria recommended by the National Osteoporosis Foundation (NOF). The 10-year Fracture Risk Assessment Tool (FRAX) scores of the hip and major osteoporotic fracture (MOF) were calculated with and without femoral neck BMD, with spine BMD, and with the trabecular bone score (TBS). Antiresorptive and anabolic agents were provided in accordance with meeting NOF criteria for treatment of osteoporosis.

Results

The mean patient age was 69.0 years, and 81% of patients were female. The mean historical height loss was 5.6 cm, and 54% of patients had a history of fracture. Secondary osteoporosis due to chronic renal failure, inflammatory arthritis, diabetes, and steroid use was common (51%). The mean 25-hydroxy vitamin D was 42.4 ng/ml and was normal in 81% of patients, with only 4 patients being deficient. The mean T-scores were -2.09 (SD 0.71) of the femoral neck, -0.54 (1.71) of the lumbar spine, and -1.65 (1.38) of the distal radius. These were significantly different. The 10-year FRAX MOF score was 20.7%, and that for hip fracture was 6.9% using the femoral neck BMD and was not significantly different without the use of BMD. The FRAX risk-adjusted score using the lumbar spine BMD and TBS was significantly lower than that for the hip. Osteoporosis was present in 32.1% according to WHO criteria compared with 81.6% according to NOF criteria. Antiresorptive medications were recommended in 31 patients and anabolic medications in 44 patients.

Conclusions

Surgeons can reliably identify patients with poor bone health by using simple criteria, including historical height loss, history of fracture, comorbidities associated with osteoporosis, analysis of available imaging, and calculation of FRAX score without BMD. High-risk patients should have BMD testing and bone health assessment. In patients with osteoporosis, a comprehensive preoperative bone health assessment is recommended and, if warranted, pharmacological treatment should be started.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^56fd1b22]. The British Journal of Surgery (2025). Medium credibility.

Inadvertently removed parathyroid glands identified at histology

In addition, the pathology report plays a crucial role in assessing the risk of hypoparathyroidism by providing objective confirmation of inadvertent parathyroid gland excision, which is a well-established risk factor for both transient and permanent hypoparathyroidism. Inadvertent parathyroidectomy during total thyroidectomy with central neck dissection for papillary thyroid carcinoma is common and involves the inferior glands more frequently in patients with extended resections and clinical N1a disease. Sitges-Serra et al.documented that transient and permanent hypoparathyroidism were more frequent after inadvertent parathyroidectomy (64% versus 46% and 15% versus 4%; P ≤ 0.03 each).

Statement 9: This minimum set of surgical core variables should include the following baseline parameters:

Patient characteristics

Consensus: Yes (8.136)

Outliers: 9

Negative outliers: 0

Evidence level: Moderate

Disease characteristics

Consensus: Yes (8.303)

Outliers: 4

Negative outliers: 0

Evidence level: Moderate

Type and extent of thyroid surgery

Consensus: Yes (8.617)

Outliers: 0

Negative outliers: 0

Evidence level: Moderate

Intraoperative number of parathyroid glands identified and preservation technique(s) including intraoperative autotransplantation, and adjuncts used

Consensus: Yes (7.966)

Outliers: 6

Negative outliers: 6

Evidence level: Moderate

Postoperative laboratory findings

Consensus: Yes (8.573)

Outliers: 1

Negative outliers: 1

Evidence level: Moderate

Supplementation with calcium and/or vitamin D/active vitamin D analogue

Consensus: Yes (8.471)

Outliers: 2

Negative outliers: 2

Evidence level: Low

Final pathology report

Consensus: Yes (7.775)

Outliers: 8

Negative outliers: 4

Evidence level: Moderate

Length of follow-up

Consensus: Yes (8.494)

Outliers: 2

Negative outliers: 1

Evidence level: Moderate

Surgical volume

Consensus: Yes (7.224)

Outliers: 14

Negative outliers: 5

Evidence level: Moderate

Bariatric surgery in anamnesis

A meta-analysis of 19 547 patients with a history of bariatric surgery has shown that they have a significantly greater risk of hypocalcaemia after thyroidectomy (30.6% versus 13.0%; OR 3.90; P = 0.005), with a heightened risk among those who have had a Roux-en-Y bypass procedure (38% versus 23%; OR 2.12; P = 0.020). Surgeons performing thyroid surgery should be aware of the increased risk of hypocalcaemia after thyroidectomy among these patients.

---

### Treatment vs prevention of head and neck cancer: are we doing our best for patients? [^9853de68]. Otolaryngology--Head and Neck Surgery (2023). Medium credibility.

Along with the relief of suffering, caring for the ill, and avoiding premature death, one of the goals of medicine is disease prevention. The majority of head and neck cancer is preventable. Every head and neck surgeon should ask whether or not our resources and efforts are being used in a manner that will provide maximum benefit to patients. In this commentary, we assess what the outcome might be if all head and neck surgeons focused solely on prevention.

---

### Vitamin D in head and neck cancer: a systematic review [^34ea921e]. Current Oncology Reports (2020). Medium credibility.

Meta-analyses and randomized controlled trials (RCT) on the effect of vitamin D on cancer risk in general have so far yielded contradictory results. In a RCT of postmenopausal women, vitamin D + calcium supplement decreased their all-cancer risk. However, another RCT found no association between vitamin D and invasive cancer risk. Based on meta-analyses, however, vitamin D supplementation does appear to be associated with lower total cancer mortality. Keum et al. found that it did not have an effect on total cancer incidence. More research is needed, with sufficiently long follow-up and assessment of the subject’s baseline 25(OH)D levels.

The role of vitamin D in HNC management has been largely ignored. Studies to date have not identified a clear clinical effect on vitamin D treatment outcome. The best evidence for the benefits of vitamin D in cancer treatment would be provided by a RCT. However, such studies have not been conducted for HNCs. They would require long follow-up periods, which affect subject compliance. Also, there is uncertainty as to the optimal dose of vitamin D for cancer treatment or prevention.

The existing studies regarding administration of vitamin D have, for example, observed a stimulating effect on the immune system of HNC patients. Walsh et al. observed that a 1,25(OH) 2 D supplement given prior to surgery increased CD4 and CD8 cell levels for 3 weeks and increased CD69 expression, suggesting T cell activation. They also found 1,25(OH) 2 D treatment to be effective in prolonging the time to recurrence of cancer. The results were not statistically significant due to the small sample size. Lathers et al. showed that 25(OH)D supplements improved the immune response of HNC patients by temporarily reducing the number of CD34-positive cells and increasing the number of IL-12 and IFN-γ-neurotransmitters. Walker et al. observed that giving 1,25(OH) 2 D treatment prior to surgery increases the plasma levels of both type 1 and type 2 T helper cell system mediators. Giving 1,25(OH) 2 D supplement also increased the levels of the tumorigenic and angiogenic mediators IL-8 and VEGF in plasma, but not in cancerous tissue.

The strength of our review is a comprehensive systematic literature search performed according to strict criteria. Results which both strengthen and weaken the association were observed, so the risk of reporting bias is low.

---

### Who wrote this clinical practice guideline? [^3e2ff96d]. Otolaryngology--Head and Neck Surgery (2015). Low credibility.

The American Academy of Otolaryngology-Head and Neck Surgery Foundation clinical practice guidelines address a variety of otolaryngologic diseases and/or procedures. It may seem reasonable to create these guidelines by assembling a team of expert clinicians familiar with the pertinent clinical issues and the available evidence, with debate and eventual agreement leading to recommendations. However, trustworthy clinical practice guidelines are in fact created via a defined process to assemble a guideline development group composed of diverse stakeholders: clinician generalists and specialists, content experts, methodologists, physicians and nonphysicians, patients, and advocates. Such a guideline development group can create a valuable and trusted guideline for clinicians and affected patients.

---

### Is GRADE the right choice for clinical practice guidelines developed by the American academy of otolaryngology-head and neck surgery foundation? [^6d8cfb68]. Otolaryngology--Head and Neck Surgery (2019). Medium credibility.

Clinical practice guidelines (CPGs), developed to inform clinicians, patients, and policy makers about what constitutes optimal clinical care, are one way of increasing implementation of evidence into clinical practice. Many factors must be considered by multidisciplinary guideline panels, including strength of available evidence, limitations of current knowledge, risks/benefits of interventions, patient values, and limited resources. Grading of Recommendations Assessment, Development and Evaluation (GRADE) is a framework for summarizing evidence that has been endorsed by many national and international organizations for developing CPGs. But is GRADE the right choice for CPGs developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF)? In this commentary, we will introduce GRADE, discuss its strengths and limitations, and address the question of what potential benefits GRADE might offer beyond existing methodology used by the AAO-HNSF in developing CPGs.

---

### Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the international association of endocrine surgeons [^fed5ea9e]. The British Journal of Surgery (2025). Medium credibility.

Reoperative thyroid surgery

Reoperative thyroid surgery is a major risk factor for hypoparathyroidism due to increased technical difficulty and compromised parathyroid integrity. In a cohort of 2108 thyroid surgeries, reoperations were associated with a higher incidence of early hypocalcaemia, especially when fewer parathyroid glands were preserved in situ. A multicentre study of 2631 patients found that completion thyroidectomy and central neck dissection significantly increased the risk of both transient and permanent hypoparathyroidism.

Statement 10: Baseline patient characteristics as part of this minimum set of surgical core variables should include the following parameters:

Sex

Consensus: Yes (7.647)

Outliers: 10

Negative outliers: 3

Evidence level: Moderate

Race and ethnicity

Consensus: No (6.227)

Outliers: 24

Negative outliers: 13

Evidence level: Not Applicable

BMI

Consensus: No (6.025)

Outliers: 10

Negative outliers: 10

Evidence level: Not Applicable

Preoperative serum calcium level

Consensus: Yes (7.640)

Outliers: 11

Negative outliers: 4

Evidence level: Moderate

Preoperative 25-OH vitamin D serum level

Consensus: Yes (7.380)

Outliers: 9

Negative outliers: 2

Evidence level: Moderate

Preoperative supplementation with calcium and/or vitamin D

Consensus: Yes (7.303)

Outliers: 15

Negative outliers: 7

Evidence level: Low

GA voting: Agree: 59.72%, Disagree: 40.28%

History of thyroid/parathyroid surgery

Consensus: Yes (8.235)

Outliers: 8

Negative outliers: 2

Evidence level: Moderate

History of bariatric surgery

Consensus: Yes (7.707)

Outliers: 9

Negative outliers: 1

Evidence level: Low

History of gastrointestinal malabsorption syndrome

Consensus: Yes (7.730)

Outliers: 12

Negative outliers: 1

Evidence level: Low

Statement 11: Baseline disease characteristics as part of this minimum set of surgical core variables should include main diagnosis and indication for surgery.

Consensus: Yes (8.343)

Outliers: 4

Negative outliers: 0

Evidence level: Moderate

---

### Cyanocobalamin (vitamin deficiency system) [^d373b46d]. FDA (2022). Medium credibility.

CONTRAINDICATIONS

Sensitivity to cobalt and/or vitamin B12is a contraindication.

---

### The use of vitamin D in preventing post-thyroidectomy hypocalcemia: an endocrinologist survey study [^e38820db]. Clinical Endocrinology (2020). Medium credibility.

Objective

To evaluate the use of preoperative vitamin D levels and postoperative vitamin D supplementation among endocrinologists for the prevention of post-thyroidectomy hypocalcaemia.

Methods

Endocrinologist members of the American Thyroid Association (ATA) were contacted via email to complete a 21-question survey, which included both questions about demographic information, and preventing and managing postoperative hypocalcaemia after thyroidectomy. Univariate and multivariate analysis was performed to determine the respondents' use of preoperative vitamin D levels, dose and duration of preoperative vitamin D repletion, decision to delay surgery for low vitamin D levels in the case of a benign or malignant disease, and routine prescription of postoperative calcium or vitamin D supplementation.

Results

225 endocrinologists who were ATA members responded to the questionnaire. When compared to endocrinologists practicing in other countries, those that practice in the United States were 2.5 times more likely to check preoperative vitamin D levels (95% CI[1.404, 4.535], P = .002), significantly more likely to replete vitamin D deficient patients with high-dose vitamin D (ie ≥50K IU/week), 4.458 times more likely to prescribe prophylactic supplemental calcium (95% CI[2.446, 8.126]; P < .0001) and 3.48 more likely to prescribe supplemental vitamin D (95% CI [1.906, 6.355]; P < .0001). Endocrinologists who have been in practice for >10 years were also 1.915 times more likely to prescribe supplemental vitamin D (95% CI (1.080, 3.395); P = .0263). Physicians that treat >50 thyroidectomy cases/year were 2.083 more likely to recommend a vitamin D repletion duration of >1 month than those that treat ≤50 cases/year ([1.036, 4.190], P = .0395). Lastly, if the patient has low preoperative vitamin D levels, 47.05% of respondents chose to delay surgery in a benign disease, while only 11.61% of respondents would do so in a case of malignant disease.

Conclusions

Approximately one-half of surveyed endocrinologists reported using preoperative vitamin D levels to assess a patient's risk for post-thyroidectomy hypocalcaemia. Endocrinologists practicing in the United States, compared to those practicing in other countries, were more likely to both test for preoperative vitamin D levels and to recommend prophylactic post-thyroidectomy calcium and vitamin D supplementation.

---

### Evidence-based perioperative nutrition recommendations: optimizing results and minimizing risks [^5f18ef0a]. Plastic and Reconstructive Surgery (2020). Medium credibility.

Plastic surgery patients span the nutritional spectrum from generally healthy, nutritionally competent patients to inherently catabolic, nutritionally deficient, and chronic wound patients. Therefore, plastic and reconstructive surgery affords the opportunity to investigate the impact of nutrition across a heterogeneous patient population following a wide variety of procedures. Although patients may be nutritionally deficient in certain vitamins warranting perioperative repletion, other supplements have the potential to benefit all patients, regardless of nutritional status. Despite these putative benefits, there is a dearth of information regarding nutritional optimization, with the limited, available literature focusing mostly on herbal supplements and their potential side effects. A significant barrier to supplement use is the lack of education and available supporting information regarding the indications, contraindications, and physiology of these adjuncts. The goal of this article is to provide a comprehensive, evidence-based review of available nutritional supplements that can be considered for the plastic surgery patient in the perioperative period to optimize surgical outcomes while minimizing risk. Prospective, well-designed studies using validated, high-quality supplements will be critical in determining the significance that perioperative supplementation can have for surgical outcomes. Until well-done prospective studies are performed, the supplement, dose, and duration should be determined on an individual, patient-per-patient basis at the discretion of the operating surgeon.

---

### Vitamin D in head and neck cancer: a systematic review [^e00c0726]. Current Oncology Reports (2020). Medium credibility.

Assessment of the Sources of Error

The sources of error of selected studies were assessed using a model developed by Viswanathan et al. the Item Bank for Assessing Risk of Bias and Confounding for Observational Studies of Interventions or Exposures.

---

### Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience [^cd91fa84]. BMC Endocrine Disorders (2023). Medium credibility.

All the patients underwent routine PTX with the removal of the suspected hyperfunctioning parathyroid glands (HPGs) in the Endocrine Surgery Department of the Clinic. Prior to surgery the following evaluations were performed: serum ionized calcium (Ca 2+), phosphorus, plasma parathyroid hormone (p-PTH), glomerular filtration rate, vitamin D, creatinine, daily urinary calcium and phosphorus excretion, renal imaging and DEXA or computerized osteodensitometry. Urolithiasis in all the cases was recorded with imaging. Renal insufficiency was defined as eGFR < 60 mL/min. The diagnosis of osteoporosis was made on the basis of the results of DEXA scans.

All operations were made via standard 4-cm Kocher incision by surgeons with extensive experience in endocrine surgery or specializing in parathyroid surgery. In all cases introoperative neuromonitoring of recurrent laryngeal nerves was used. Bilateral neck exploration with the visualization of all fours glands was also performed in cases where multiglandular disease had not been reliably ruled out before the operation. Intraoperative level of p-PTH was not routinely measured. Levels of Ca 2 + and p-PTH were measured 1 day after surgery. Decrease of p-PTH lower high reference level and decrease of Ca 2 + to the target level were achieved for all the patients. In all cases postoperative pathology was also performed. Frozen sections were not used.

When discharged from the hospital after PTX, the patients were given recommendations for taking calcium and active forms of vitamin D under the control of phosphorus-calcium metabolism indicators. The success of surgery was confirmed by normalization of Ca 2 + and p-PTH on the first day after surgery. After the discharge from the hospital the levels of Ca 2+, p-PTH, 25OHD and other biochemical parameters were controlled on the outpatients’ basis in polyclinics by local endocrinologist or general practitioner in accordance with clinical guidelines.

Patients who agreed to complete QoL questionnaires electronically were included in QoL follow-up.

For QoL assessment generic QoL questionnaire RAND SF-36 and specific questionnaire PHPQoL were used. The prevalence and severity of symptoms were analysed on the basis of specific symptom assessment questionnaire for PHPT – PAS.

---

### Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American college of surgeons national surgical quality improvement program and the American Geriatrics Society [^9b03db2e]. Journal of the American College of Surgeons (2012). Medium credibility.

Preoperative interventions for malnutrition—ESPEN Recommendations outline to use nutritional support in patients with severe nutritional risk for 10–14 days prior to a major surgical operation even if the operation has to be delayed (Grade A), and to initiate nutritional support (by the enteral route if possible) without delay even in patients without obvious under-nutrition if it is anticipated that the patient will be unable to eat for more than 7 days perioperatively (Grade C) and in patients who cannot maintain oral intake above 60% of recommended intake for more than 10 days (Grade C). Consider combination with parenteral nutrition in patients in whom energy needs cannot be met (<60% of caloric requirement) via the enteral route (Grade C), encourage patients who do not meet their energy needs from normal food to take oral nutritional supplements during the preoperative period (Grade C), and administer preoperative enteral nutrition preferably before admission to the hospital (Grade C). Preoperative parenteral nutrition is indicated in severely undernourished patients who cannot be adequately orally or enterally fed for 7–10 days preoperatively (Grade A). The enteral route is preferred except for the following contraindications: intestinal obstructions or ileus, severe shock, intestinal ischemia. Other recommendations include vitamin supplementation for alcohol-related malnourished patient: B12 and folate, thiamine.

---

### Preoperative and postoperative optimisation of patients undergoing thyroid surgery: a multicentre quality improvement project at barts health NHS trust [^fdbe2122]. BMJ Open Quality (2023). High credibility.

Cycle 2

The PA was carried out between April and July 2019, 6 months after the guidelines were initially disseminated, with the improvement cycles occurring during this time period. The compliance with the new postoperative hypocalcaemia guidelines was 78.3%, the preoperative optimisation guideline increased the number of patients being tested for preoperative vitamin D testing, but compliance with consequent treatment of the deficiency was limited due to doctors not readily available in the preassessment clinics.

A group meeting with all members of the preoperative assessment was conducted to discuss issues regarding compliance. The team were finding it difficult to engage with the guidelines, as it was thought to be extra work in an already busy clinic—with similar issues regarding prescribing and chasing results for the additional blood tests requested. An additional method to contact the junior ENT doctors was provided through a group email address that could be used to alert all junior doctors of abnormal blood results. A patient information leaflet was also suggested so that the preoperative nurses could inform patients of the possibility of requiring vitamin D supplementation preoperatively if they were deficient. This could be incorporated into the standard preoperative instructions leaflet provided to all patients attending clinic.

---